package org.qsari.effectopedia.data.generated;
import org.qsari.effectopedia.core.objects.DescriptionSection;
import org.qsari.effectopedia.core.objects.DescriptionSection.ContentFormat;
import org.qsari.effectopedia.core.objects.DescriptionSection_Structured;
import org.qsari.effectopedia.core.objects.Effect_AdverseOutcome;
import org.qsari.effectopedia.core.objects.Effect_DownstreamEffect;
import org.qsari.effectopedia.core.objects.Effect_Endpoint;
import org.qsari.effectopedia.core.objects.Effect_MolecularInitiatingEvent;
import org.qsari.effectopedia.core.objects.Initiator_ChemicalStructure;
import org.qsari.effectopedia.core.objects.Link;
import org.qsari.effectopedia.core.objects.Link_ChemStructToMIE;
import org.qsari.effectopedia.core.objects.Link_EffectToEffect;
import org.qsari.effectopedia.core.objects.Method_Investigation;
import org.qsari.effectopedia.core.objects.Method_Study;
import org.qsari.effectopedia.core.objects.Pathway;
import org.qsari.effectopedia.core.objects.Reference;
import org.qsari.effectopedia.core.objects.SubstanceData;
import org.qsari.effectopedia.core.objects.TestResponseMapping;
import org.qsari.effectopedia.core.objects.Test_InVitro;
import org.qsari.effectopedia.core.objects.Test_InVivo;
import org.qsari.effectopedia.core.objects.Test_ExVivo;
import org.qsari.effectopedia.data.DataSource;
import org.qsari.effectopedia.data.objects.ObjectProperties;
import org.qsari.effectopedia.data.objects.ObjectPropertyMultivalued_Documented;
import org.qsari.effectopedia.defaults.DefaultDataTemplates;
import org.qsari.effectopedia.defaults.DefaultEffectopediaObjects;
import org.qsari.effectopedia.system.User;
import org.qsari.effectopedia.data.RevisionBasedDS;
import org.qsari.effectopedia.core.objects.Link.LinkType;
import org.qsari.effectopedia.base.ids.ReferenceIDW;
import org.qsari.effectopedia.core.object.elemets.EssetialityDescription;

public class AOP	extends SourceGeneratedPathway {

public AOP(DataSource dataSource) {
super("PPARα activation in utero leading to impaired fertility in males","",dataSource,"D://Java//org.qsari.effectopedia//test//PPARα activation in utero leading to impaired fertility in males");
}
public AOP(DataSource dataSource, boolean autoSave) {
super("PPARα activation in utero leading to impaired fertility in males","",dataSource,"D://Java//org.qsari.effectopedia//test//PPARα activation in utero leading to impaired fertility in males",autoSave);
}
protected Effect_MolecularInitiatingEvent effect_molecularinitiatingevent1;//3102
protected Effect_AdverseOutcome effect_adverseoutcome2;//3110
protected Effect_AdverseOutcome effect_adverseoutcome3;//3117
protected Effect_DownstreamEffect effect_downstreameffect4;//3126
protected Effect_DownstreamEffect effect_downstreameffect5;//3133
protected Link_EffectToEffect link_effecttoeffect6;//3140
protected Effect_DownstreamEffect effect_downstreameffect7;//3157
protected Link_EffectToEffect link_effecttoeffect8;//3164
protected Effect_DownstreamEffect effect_downstreameffect9;//3179
protected Link_EffectToEffect link_effecttoeffect10;//3186
protected Link_EffectToEffect link_effecttoeffect11;//3201
protected Effect_DownstreamEffect effect_downstreameffect12;//3216
protected Link_EffectToEffect link_effecttoeffect13;//3223
protected Effect_DownstreamEffect effect_downstreameffect14;//3237
protected Link_EffectToEffect link_effecttoeffect15;//3244
protected Link_EffectToEffect link_effecttoeffect16;//3259
@Override
public void generateContent()
{genreateRevision1();
storeRevision();
if (dataSource instanceof RevisionBasedDS)
((RevisionBasedDS) dataSource).setLocation(pathway);
}
public void genreateRevision1() {

effect_molecularinitiatingevent1 = new Effect_MolecularInitiatingEvent(pathway, dataSource);
effect_molecularinitiatingevent1.setTitle("Activation, PPARα");
effect_molecularinitiatingevent1.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_LBO.DIMENSION_INDEX, "molecular");
effect_molecularinitiatingevent1.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_TAXONOMY.DIMENSION_INDEX, "Rattus norvegicus, Mus musculus, Homo sapiens");
effect_molecularinitiatingevent1.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_SEX.DIMENSION_INDEX, "male");
effect_molecularinitiatingevent1.getDescriptionIDs().set(new DescriptionSection(effect_molecularinitiatingevent1,dataSource,"Description","<div class='description'><h3>Description</h3><p><p><b>Biological state</b>\n\n</p><p>The Peroxisome Proliferator Activated receptor α (PPARα) belongs to the  <a href=\"/wiki/index.php/Peroxisome_Proliferator_Activated_receptors_(PPARs;_NR1C)\" title=\"Peroxisome Proliferator Activated receptors (PPARs; NR1C)\">Peroxisome Proliferator Activated receptors (PPARs; NR1C)</a> steroid/thyroid/retinoid receptor superfamily of transcription factors.\n\n</p><p><b>Biological compartments</b>\n\n</p><p>PPARα is expressed in high levels in tissues that perform significant catabolism of fatty acids (FAs), such as brown adipose tissue, liver, heart, kidney, and intestine (Michalik et al. 2006). The receptor is present also in skeletal muscle, intestine, pancreas, lung, placenta and testes (Mukherjee et al. 1997), (Schultz et al. 1999). \n\n</p><p><b>General role in biology</b>\n\n</p><p>PPARs are activated by fatty acids and their derivatives; they are sensors of dietary lipids and are involved in lipid and carbohydrate metabolism, immune response and peroxisome proliferation (Wahli and Desvergne 1999), (Evans, Barish, &amp; Wang, 2004). PAPRα is a also a target of hypothalamic hormone signalling and was found to play a role in embryonic development (Yessoufou and Wahli 2010).\n\n</p><p>Fibrates, activators of PPARα, are commonly used to treat hypertriglyceridemia and other dyslipidemic states as they have been shown to decrease circulating lipid levels (Lefebvre et al. 2006).\n\n</p></p></div><div class='references'><h3>References</h3><p><p>Bhattacharya, Nandini, Jannette M Dufour, My-Nuong Vo, Janice Okita, Richard Okita, and Kwan Hee Kim. 2005. “Differential Effects of Phthalates on the Testis and the Liver.” Biology of Reproduction 72 (3) (March): 745–54. doi:10.1095/biolreprod.104.031583.\n\n</p><p>Bility, Moses T, Jerry T Thompson, Richard H McKee, Raymond M David, John H Butala, John P Vanden Heuvel, and Jeffrey M Peters. 2004. “Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors (PPARs) by Phthalate Monoesters.” Toxicological Sciences : An Official Journal of the Society of Toxicology 82 (1) (November): 170–82. doi:10.1093/toxsci/kfh253.\n\n</p><p>Dufour, Jannette M, My-Nuong Vo, Nandini Bhattacharya, Janice Okita, Richard Okita, and Kwan Hee Kim. 2003. “Peroxisome Proliferators Disrupt Retinoic Acid Receptor Alpha Signaling in the Testis.” Biology of Reproduction 68 (4) (April): 1215–24. doi:10.1095/biolreprod.102.010488.\n\n</p><p>Feige, Jérôme N, Laurent Gelman, Daniel Rossi, Vincent Zoete, Raphaël Métivier, Cicerone Tudor, Silvia I Anghel, et al. 2007. “The Endocrine Disruptor Monoethyl-Hexyl-Phthalate Is a Selective Peroxisome Proliferator-Activated Receptor Gamma Modulator That Promotes Adipogenesis.” The Journal of Biological Chemistry 282 (26) (June 29): 19152–66. doi:10.1074/jbc.M702724200.\n\n</p><p>Hurst, Christopher H, and David J Waxman. 2003. “Activation of PPARalpha and PPARgamma by Environmental Phthalate Monoesters.” Toxicological Sciences : An Official Journal of the Society of Toxicology 74 (2) (August): 297–308. doi:10.1093/toxsci/kfg145.\n\n</p><p>Kaya, Taner, Scott C Mohr, David J Waxman, and Sandor Vajda. 2006. “Computational Screening of Phthalate Monoesters for Binding to PPARgamma.” Chemical Research in Toxicology 19 (8) (August): 999–1009. doi:10.1021/tx050301s.\n\n</p><p>Lampen, Alfonso, Susan Zimnik, and Heinz Nau. 2003. “Teratogenic Phthalate Esters and Metabolites Activate the Nuclear Receptors PPARs and Induce Differentiation of F9 Cells.” Toxicology and Applied Pharmacology 188 (1) (April): 14–23. doi:10.1016/S0041-008X(03)00014-0.\n\n</p><p>Lapinskas, Paula J., Sherri Brown, Lisa M. Leesnitzer, Steven Blanchard, Cyndi Swanson, Russell C. Cattley, and J. Christopher Corton. 2005. “Role of PPARα in Mediating the Effects of Phthalates and Metabolites in the Liver.” Toxicology 207 (1): 149–163.\n\n</p><p>Le Maire, Albane, Marina Grimaldi, Dominique Roecklin, Sonia Dagnino, Valérie Vivat-Hannah, Patrick Balaguer, and William Bourguet. 2009. “Activation of RXR-PPAR Heterodimers by Organotin Environmental Endocrine Disruptors.” EMBO Reports 10 (4) (April): 367–73. doi:10.1038/embor.2009.8.\n\n</p><p>LeBlanc, GA, DO Norris, and W Kloas. 2011. “Detailed Review Paper State of the Science on Novel In Vitro and In Vivo Screening and Testing Methods and Endpoints for Evaluating Endocrine Disruptors” (178).\n\n</p><p>Lefebvre, Philippe, Giulia Chinetti, Jean-Charles Fruchart, and Bart Staels. 2006. “Sorting out the Roles of PPAR Alpha in Energy Metabolism and Vascular Homeostasis.” The Journal of Clinical Investigation 116 (3) (March): 571–80. doi:10.1172/JCI27989.\n\n</p><p>Maloney, Erin K., and David J. Waxman. 1999. “Trans-Activation of PPARα and PPARγ by Structurally Diverse Environmental Chemicals.” Toxicology and Applied Pharmacology 161 (2): 209–218.\n\n</p><p>Michalik, Liliane, Johan Auwerx, Joel P Berger, V Krishna Chatterjee, Christopher K Glass, Frank J Gonzalez, Paul A Grimaldi, et al. 2006. “International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors.” Pharmacological Reviews 58 (4) (December): 726–41. doi:10.1124/pr.58.4.5.\n\n</p><p>Mukherjee, R, L Jow, G E Croston, and J R Paterniti. 1997. “Identification, Characterization, and Tissue Distribution of Human Peroxisome Proliferator-Activated Receptor (PPAR) Isoforms PPARgamma2 versus PPARgamma1 and Activation with Retinoid X Receptor Agonists and Antagonists.” The Journal of Biological Chemistry 272 (12) (March 21): 8071–6.\n\n</p><p>Schultz, R, W Yan, J Toppari, A Völkl, J A Gustafsson, and M Pelto-Huikko. 1999. “Expression of Peroxisome Proliferator-Activated Receptor Alpha Messenger Ribonucleic Acid and Protein in Human and Rat Testis.” Endocrinology 140 (7) (July): 2968–75. doi:10.1210/endo.140.7.6858.\n\n</p><p>Staels, B., J. Dallongeville, J. Auwerx, K. Schoonjans, E. Leitersdorf, and J.-C. Fruchart. 1998. “Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism.” Circulation 98 (19) (November 10): 2088–2093. doi:10.1161/01.CIR.98.19.2088.\n\n</p><p>ToxCastTM Data. “ToxCastTM Data.” US Environmental Protection Agency. <a rel=\"nofollow\" target=\"_blank\" class=\"external free\" href=\"http://www.epa.gov/ncct/toxcast/data.html\">http://www.epa.gov/ncct/toxcast/data.html</a>\n\n</p><p>Vanden Heuvel, John P, Jerry T Thompson, Steven R Frame, and Peter J Gillies. 2006. “Differential Activation of Nuclear Receptors by Perfluorinated Fatty Acid Analogs and Natural Fatty Acids: A Comparison of Human, Mouse, and Rat Peroxisome Proliferator-Activated Receptor-Alpha, -Beta, and -Gamma, Liver X Receptor-Beta, and Retinoid X Rec.” Toxicological Sciences : An Official Journal of the Society of Toxicology 92 (2) (August): 476–89. doi:10.1093/toxsci/kfl014.\n\n</p><p>Venkata, Nagaraj Gopisetty, Jodie a Robinson, Peter J Cabot, Barbara Davis, Greg R Monteith, and Sarah J Roberts-Thomson. 2006. “Mono(2-Ethylhexyl)phthalate and Mono-N-Butyl Phthalate Activation of Peroxisome Proliferator Activated-Receptors Alpha and Gamma in Breast.” Toxicology Letters 163 (3) (June 1): 224–34. doi:10.1016/j.toxlet.2005.11.001.\n\n</p><p>Viswakarma, Navin, Yuzhi Jia, Liang Bai, Aurore Vluggens, Jayme Borensztajn, Jianming Xu, and Janardan K Reddy. 2010. “Coactivators in PPAR-Regulated Gene Expression.” PPAR Research 2010 (January). doi:10.1155/2010/250126.\n\n</p><p>Wahli, Walter, and B Desvergne. 1999. “Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism.” Endocrine Reviews 20 (5) (October): 649–88.\n\nWu, Bin, Jie Gao, and Ming-wei Wang. 2005. “Development of a Complex Scintillation Proximity Assay for High-Throughput Screening of PPARgamma Modulators.” Acta Pharmacologica Sinica 26 (3) (March): 339–44. doi:10.1111/j.1745-7254.2005.00040.x.\n\n</p><p>Xu, Chuan, Ji-An Chen, Zhiqun Qiu, Qing Zhao, Jiaohua Luo, Lan Yang, Hui Zeng, et al. 2010. “Ovotoxicity and PPAR-Mediated Aromatase Downregulation in Female Sprague-Dawley Rats Following Combined Oral Exposure to Benzo[a]pyrene and Di-(2-Ethylhexyl) Phthalate.” Toxicology Letters 199 (3) (December 15): 323–32. doi:10.1016/j.toxlet.2010.09.015.\n\n</p><p>Yessoufou, a, and W Wahli. 2010. “Multifaceted Roles of Peroxisome Proliferator-Activated Receptors (PPARs) at the Cellular and Whole Organism Levels.” Swiss Medical Weekly 140 (September) (January): w13071. doi:10.4414/smw.2010.13071.\n\n</p><p>Yu, Songtao, and Janardan K Reddy. 2007. “Transcription Coactivators for Peroxisome Proliferator-Activated Receptors.” Biochimica et Biophysica Acta 1771 (8) (August): 936–51. doi:10.1016/j.bbalip.2007.01.008.\n\n</p></p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Effect_MolecularInitiatingEvent> effect_molecularinitiatingevent1_weigth1= new ReferenceIDW<Effect_MolecularInitiatingEvent>(effect_molecularinitiatingevent1, dataSource, Effect_MolecularInitiatingEvent.class,1.0);
effect_molecularinitiatingevent1.getDescriptionIDs().set(new DescriptionSection_Structured(effect_molecularinitiatingevent1,dataSource,"(Key) Event Essentiality","", effect_molecularinitiatingevent1_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);

effect_adverseoutcome2 = new Effect_AdverseOutcome(pathway, dataSource);
effect_adverseoutcome2.setTitle("impaired, Fertility");
effect_adverseoutcome2.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_LBO.DIMENSION_INDEX, "individual");
effect_adverseoutcome2.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_TAXONOMY.DIMENSION_INDEX, "Rattus norvegicus, Mus musculus, Homo sapiens");
effect_adverseoutcome2.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_SEX.DIMENSION_INDEX, "male");
effect_adverseoutcome2.getDescriptionIDs().set(new DescriptionSection(effect_adverseoutcome2,dataSource,"Description","<div class='description'><h3>Description</h3><p><p><strong>Biological state</strong></p>\n\n<p>capability to produce offspring</p>\n\n<p><strong>Biological compartments</strong></p>\n\n<p>System</p>\n\n<p><strong>General role in biology</strong></p>\n\n<p>Fertility is the capacity to conceive or induce conception. Impairment of fertility represents disorders of male or female reproductive functions or capacity.</p>\n\n</p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Effect_AdverseOutcome> effect_adverseoutcome2_weigth1= new ReferenceIDW<Effect_AdverseOutcome>(effect_adverseoutcome2, dataSource, Effect_AdverseOutcome.class,0.0);
effect_adverseoutcome2.getDescriptionIDs().set(new DescriptionSection_Structured(effect_adverseoutcome2,dataSource,"(Key) Event Essentiality","", effect_adverseoutcome2_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);

effect_adverseoutcome3 = new Effect_AdverseOutcome(pathway, dataSource);
effect_adverseoutcome3.setTitle("Malformation, Male reproductive tract");
effect_adverseoutcome3.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_LBO.DIMENSION_INDEX, "organ");
effect_adverseoutcome3.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_TAXONOMY.DIMENSION_INDEX, "Homo sapiens, Rattus norvegicus");
effect_adverseoutcome3.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_SEX.DIMENSION_INDEX, "male");
effect_adverseoutcome3.getDescriptionIDs().set(new DescriptionSection(effect_adverseoutcome3,dataSource,"Description","<div class='description'><h3>Description</h3><p><p><strong>Biological state</strong></p>\n\n<p><strong>Male reproductive tract malformations</strong> (congenital malformation of male genitalia) comprise any physical abnormality of the male internal or external genitalia present at birth. Some result from excessive or deficient androgen effect, others result from teratogenic effects, or are associated with anomalies of other parts of the body in a recognizable pattern (i.e., a syndrome). The cause of many of these birth defects is unknown.</p>\n\n<p><strong>Hypospadias</strong> is a defect of the urogenital system, a malformation in which the urethra opens on the underside of the penis instead of the tip. It results from an incomplete closure of the urethral folds, leaving a split on the penis (Kalfa, Philibert, and Sultan 2009). When the urethra opens to the glans or corona of the penis, it is called distal, whereas opening to the shaft or penoscrotal area defines hypospadias as proximal. Androgens regulate the masculinization of external genitalia. Therefore any defects in androgen biosynthesis, metabolism or action during foetal development can cause hypospadias. Gene defects causing disorders of testicular differentiation, conversion of testosterone to dihydrotestosterone or mutations in the androgen receptor can also result in hypospadias (Kalfa et al. 2008). In about 20% of patients with isolated hypospadias there are signs of endocrine abnormalities by the time of diagnosis (Rey et al. 2005). The majority of hypospadias are believed to have a multifactorial etiology, although a small percentage do result from single gene mutations (Baskin, Himes, and Colborn 2001). The only treatment of hypospadias is surgery, thus, prevention is imperative.</p>\n\n<p><br />\n\n<strong>Biological compartments</strong>: reproductive system</p>\n\n</p></div><div class='references'><h3>References</h3><p><p><br />\n\nArbuckle, Tye E, Russ Hauser, Shanna H Swan, Catherine S Mao, Matthew P Longnecker, Katharina M Main, Robin M Whyatt, et al. 2008. &ldquo;Meeting Report: Measuring Endocrine-Sensitive Endpoints within the First Years of Life.&rdquo; Environmental Health Perspectives 116 (7) (July): 948&ndash;51. doi:10.1289/ehp.11226.</p>\n\n<p>Barrett, Emily S, Lauren E Parlett, J Bruce Redmon, and Shanna H Swan. 2014. &ldquo;Evidence for Sexually Dimorphic Associations between Maternal Characteristics and Anogenital Distance, a Marker of Reproductive Development.&rdquo; American Journal of Epidemiology 179 (1) (January 1): 57&ndash;66. doi:10.1093/aje/kwt220.</p>\n\n<p>Baskin, L S, K Himes, and T Colborn. 2001. &ldquo;Hypospadias and Endocrine Disruption: Is There a Connection?&rdquo; Environmental Health Perspectives 109 (11) (November): 1175&ndash;83.</p>\n\n<p>Bowman, Christopher J, Norman J Barlow, Katie J Turner, Duncan G Wallace, and Paul M D Foster. 2003. &ldquo;Effects of in Utero Exposure to Finasteride on Androgen-Dependent Reproductive Development in the Male Rat.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 74 (2) (August): 393&ndash;406. doi:10.1093/toxsci/kfg128.</p>\n\n<p>Dean, Afshan, and Richard M Sharpe. 2013. &ldquo;Clinical Review: Anogenital Distance or Digit Length Ratio as Measures of Fetal Androgen Exposure: Relationship to Male Reproductive Development and Its Disorders.&rdquo; The Journal of Clinical Endocrinology and Metabolism 98 (6) (June): 2230&ndash;8. doi:10.1210/jc.2012-4057.</p>\n\n<p>Gray, L E, J Ostby, J Furr, C J Wolf, C Lambright, L Parks, D N Veeramachaneni, et al. 2001. &ldquo;Effects of Environmental Antiandrogens on Reproductive Development in Experimental Animals.&rdquo; Human Reproduction Update 7 (3): 248&ndash;64.</p>\n\n<p>Hayes, Tyrone B, Atif Collins, Melissa Lee, Magdelena Mendoza, Nigel Noriega, A Ali Stuart, and Aaron Vonk. 2002. &ldquo;Hermaphroditic, Demasculinized Frogs after Exposure to the Herbicide Atrazine at Low Ecologically Relevant Doses.&rdquo; Proceedings of the National Academy of Sciences of the United States of America 99 (8) (April 16): 5476&ndash;80. doi:10.1073/pnas.082121499.</p>\n\n<p>Howdeshell, Kembra L, Johnathan Furr, Christy R Lambright, Cynthia V Rider, Vickie S Wilson, and L Earl Gray. 2007. &ldquo;Cumulative Effects of Dibutyl Phthalate and Diethylhexyl Phthalate on Male Rat Reproductive Tract Development: Altered Fetal Steroid Hormones and Genes.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 99 (1) (September): 190&ndash;202. doi:10.1093/toxsci/kfm069.</p>\n\n<p>Kalfa, Nicolas, Benchun Liu, Ophir Klein, Ming-Hsieh Wang, Mei Cao, and Laurence S Baskin. 2008. &ldquo;Genomic Variants of ATF3 in Patients with Hypospadias.&rdquo; The Journal of Urology 180 (5) (November): 2183&ndash;8; discussion 2188. doi:10.1016/j.juro.2008.07.066.</p>\n\n<p>Kalfa, Nicolas, Pascal Philibert, and Charles Sultan. 2009. &ldquo;Is Hypospadias a Genetic, Endocrine or Environmental Disease, or Still an Unexplained Malformation?&rdquo; International Journal of Andrology 32 (3) (June): 187&ndash;97. doi:10.1111/j.1365-2605.2008.00899.x.</p>\n\n<p>Macleod, D J, R M Sharpe, M Welsh, M Fisken, H M Scott, G R Hutchison, A J Drake, and S van den Driesche. 2010. &ldquo;Androgen Action in the Masculinization Programming Window and Development of Male Reproductive Organs.&rdquo; International Journal of Andrology 33 (2) (April): 279&ndash;87. doi:10.1111/j.1365-2605.2009.01005.x.</p>\n\n<p>Manson, Jeanne M, and Michael C Carr. 2003. &ldquo;Molecular Epidemiology of Hypospadias: Review of Genetic and Environmental Risk Factors.&rdquo; Birth Defects Research. Part A, Clinical and Molecular Teratology 67 (10) (October): 825&ndash;36. doi:10.1002/bdra.10084.</p>\n\n<p>McIntyre, B S, N J Barlow, and P M Foster. 2001. &ldquo;Androgen-Mediated Development in Male Rat Offspring Exposed to Flutamide in Utero: Permanence and Correlation of Early Postnatal Changes in Anogenital Distance and Nipple Retention with Malformations in Androgen-Dependent Tissues.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 62 (2) (August): 236&ndash;49.</p>\n\n<p>Mendiola, Jaime, Manuela Roca, Lidia M&iacute;nguez-Alarc&oacute;n, Maria-Pilar Mira-Escolano, Jos&eacute; J L&oacute;pez-Esp&iacute;n, Emily S Barrett, Shanna H Swan, and Alberto M Torres-Cantero. 2012. &ldquo;Anogenital Distance Is Related to Ovarian Follicular Number in Young Spanish Women: A Cross-Sectional Study.&rdquo; Environmental Health : A Global Access Science Source 11 (January): 90. doi:10.1186/1476-069X-11-90.</p>\n\n<p>OECD. 2012. Test No. 443: Extended One-Generation Reproductive Toxicity Study. OECD Guidelines for the Testing of Chemicals, Section 4. OECD Publishing. doi:10.1787/9789264185371-en.</p>\n\n<p>Rey, Rodolfo A, Ethel Codner, Germ&aacute;n I&ntilde;&iacute;guez, Patricia Bedecarr&aacute;s, Romina Trigo, Cecilia Okuma, Silvia Gottlieb, Ignacio Bergad&aacute;, Stella M Campo, and Fernando G Cassorla. 2005. &ldquo;Low Risk of Impaired Testicular Sertoli and Leydig Cell Functions in Boys with Isolated Hypospadias.&rdquo; The Journal of Clinical Endocrinology and Metabolism 90 (11) (November): 6035&ndash;40. doi:10.1210/jc.2005-1306.</p>\n\n<p>Wolf, C., C. Lambright, P. Mann, M. Price, R. L. Cooper, J. Ostby, and L. E. Gray. 1999. &ldquo;Administration of Potentially Antiandrogenic Pesticides (procymidone, Linuron, Iprodione, Chlozolinate, P,p&rsquo;-DDE, and Ketoconazole) and Toxic Substances (dibutyl- and Diethylhexyl Phthalate, PCB 169, and Ethane Dimethane Sulphonate) during Sexual Differen.&rdquo; Toxicology and Industrial Health 15 (1-2) (February 1): 94&ndash;118. doi:10.1177/074823379901500109.</p>\n\n</p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Effect_AdverseOutcome> effect_adverseoutcome3_weigth1= new ReferenceIDW<Effect_AdverseOutcome>(effect_adverseoutcome3, dataSource, Effect_AdverseOutcome.class,0.0);
effect_adverseoutcome3.getDescriptionIDs().set(new DescriptionSection_Structured(effect_adverseoutcome3,dataSource,"(Key) Event Essentiality","", effect_adverseoutcome3_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);

effect_downstreameffect4 = new Effect_DownstreamEffect(pathway, dataSource);
effect_downstreameffect4.setTitle("Decrease, Steroidogenic acute regulatory protein (STAR)");
effect_downstreameffect4.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_LBO.DIMENSION_INDEX, "cellular");
effect_downstreameffect4.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_TAXONOMY.DIMENSION_INDEX, "Mus musculus, Homo sapiens, Rattus norvegicus");
effect_downstreameffect4.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_SEX.DIMENSION_INDEX, "male");
effect_downstreameffect4.getDescriptionIDs().set(new DescriptionSection(effect_downstreameffect4,dataSource,"Description","<div class='description'><h3>Description</h3><p><p><b>Biological state</b>\n\n</p><p>Steroidogenic acute regulatory protein (StAR) functions as a cholesterol transfer protein and acts directly on lipids of the outer mitochondrial membrane to promote cholesterol translocation (Stocco 2001). Reduction of the protein impacts on the amount of substrate available for steroidogenesis. \n\n</p><p><br />\n\n<b>Biological compartments</b>\n\n</p><p>StAR is expressed principally in steroidogenic tissues (Bauer et al. 2000).\n\n</p><p><b>General role in biology</b>\n\n</p><p>StAR is required for cholesterol shuttling across the mitochondrial membrane and appears to regulate acute steroid production (Clark and Stocco, 1997). Transcriptional or translational inhibition of StAR expression results in a dramatic decrease in steroid biosynthesis, whereas ~10–15% of steroid synthesis appears to be mediated through StAR-independent mechanisms (Manna et al. 2001) (Clark and Stocco, 1997).\n\nIn contrast, chronically regulated steroid production appears to be largely mediated by increased transcription of steroidogenic enzymes (Hum and Miller 1993).\n\n</p></p></div><div class='references'><h3>References</h3><p><p>Bauer, M P, J T Bridgham, D M Langenau, A L Johnson, and F W Goetz. 2000. “Conservation of Steroidogenic Acute Regulatory (StAR) Protein Structure and Expression in Vertebrates.” Molecular and Cellular Endocrinology 168 (1-2) (October 25): 119–25.\n\n</p><p>Hum, D W, and W L Miller. 1993. “Transcriptional Regulation of Human Genes for Steroidogenic Enzymes.” Clinical Chemistry 39 (2) (February): 333–40.\n\n</p><p>Manna, P R, J Kero, M Tena-Sempere, P Pakarinen, D M Stocco, and I T Huhtaniemi. 2001. “Assessment of Mechanisms of Thyroid Hormone Action in Mouse Leydig Cells: Regulation of the Steroidogenic Acute Regulatory Protein, Steroidogenesis, and Luteinizing Hormone Receptor Function.” Endocrinology 142 (1) (January): 319–31. doi:10.1210/endo.142.1.7900.\n\n</p><p>Stocco, D M. 2001. “StAR Protein and the Regulation of Steroid Hormone Biosynthesis.” Annual Review of Physiology 63 (January): 193–213. doi:10.1146/annurev.physiol.63.1.193.\n\n</p></p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Effect_DownstreamEffect> effect_downstreameffect4_weigth1= new ReferenceIDW<Effect_DownstreamEffect>(effect_downstreameffect4, dataSource, Effect_DownstreamEffect.class,1.0);
effect_downstreameffect4.getDescriptionIDs().set(new DescriptionSection_Structured(effect_downstreameffect4,dataSource,"(Key) Event Essentiality","", effect_downstreameffect4_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);

effect_downstreameffect5 = new Effect_DownstreamEffect(pathway, dataSource);
effect_downstreameffect5.setTitle("Reduction, Cholesterol transport in mitochondria");
effect_downstreameffect5.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_LBO.DIMENSION_INDEX, "cellular");
effect_downstreameffect5.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_TAXONOMY.DIMENSION_INDEX, "Mus musculus, Homo sapiens, Rattus norvegicus");
effect_downstreameffect5.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_SEX.DIMENSION_INDEX, "male");
effect_downstreameffect5.getDescriptionIDs().set(new DescriptionSection(effect_downstreameffect5,dataSource,"Description","<div class='description'><h3>Description</h3><p><p><b>Biological state</b>\n\n</p><p>Steroidogenesis begins with the transport of cholesterol from intracellular stores into mitochondria. This process involves a series of protein-protein interactions involving cytosolic and mitochondrial proteins located at both the outer and inner mitochondrial membranes. In steroidogenic cells the cholesterol import to the mitochondrial inner membrane is crucial for steroid synthesis (Rone, Fan, and Papadopoulos 2009). This process is facilitated by the Scavenger Receptor Class B, type 1 (SR-B1) [more relevant for rodents, than for humans] that mediates the selective uptake of cholesterol esters from high-density lipoproteins. Steroidogenic acute regulatory protein (STAR) and the translator protein (TSPO) [former peripheral benzodiazepine receptor (PBR)]  mediate cholesterol transport from the outer to the inner mitochondrial membrane. The conversion of cholesterol to pregnenolone is done by Cholesterol side-chain cleavage enzyme (P450scc), the start of steroidogenesis [reviewed in (Miller and Auchus 2011)].\n\n</p><p><br />\n\n<b>Biological compartments</b>\n\n</p><p>In mitochondria of steroidogenic tissues there are two specialized mechanisms related to hormone synthesis: one by which cholesterol is delivered to the mitochondria and the other by which specialized intra-mitochondrial enzymes participate in the synthesis of hormonal steroids. \n\n</p><p><br />\n\n</p><p><b>General role in biology</b>\n\n</p><p>Systemic steroid hormones are primarily formed by the gonads, adrenal glands, and during in utero development by the placenta. Some other organs like brain (Baulieu 1998), and heart (Kayes-Wandover and White 2000) have also been identified as steroid-producing tissues, mainly for local needs. The steroid hormones are indispensable for mammalian life. They are made from cholesterol via complex biosynthetic pathways that are initiated by specialized, tissue-specific enzymes in mitochondria. These hormones include glucocorticoids (cortisol, corticosterone) and mineralocorticoids (aldosterone) produced in the adrenal cortex, estrogens (estradiol), progestins (progesterone) and androgens (testosterone, dihydrotestosterone) produced in the gonads, and calciferols (1,25-dihydroxy vitamin D [1,25OH2D]) produced in the kidneys (Miller and Auchus 2011). Cholesterol is the precursor for the synthesis of steroid hormones in mitochondria. Steroidogenesis begins with the metabolism of cholesterol to pregnenolone facilitated by P450scc. The rate of steroid formation depends on the rate of cholesterol transport from intracellular stores to the inner mitochondrial membrane and the loading of P450scc with cholesterol (Miller and Auchus 2011). \n\nInterference with one or more of these reactions leads to reduced steroid production.\n\n</p></p></div><div class='references'><h3>References</h3><p><p>Albalat, Ricard, Frédéric Brunet, Vincent Laudet, and Michael Schubert. 2011. “Evolution of Retinoid and Steroid Signaling: Vertebrate Diversification from an Amphioxus Perspective.” Genome Biology and Evolution 3: 985–1005. doi:10.1093/gbe/evr084.\n\n</p><p>Baulieu, E E. 1998. “Neurosteroids: A Novel Function of the Brain.” Psychoneuroendocrinology 23 (8) (November): 963–87.\n\n</p><p>Charman, Mark, Barry E Kennedy, Nolan Osborne, and Barbara Karten. 2010. “MLN64 Mediates Egress of Cholesterol from Endosomes to Mitochondria in the Absence of Functional Niemann-Pick Type C1 Protein.” Journal of Lipid Research 51 (5) (May): 1023–34. doi:10.1194/jlr.M002345.\n\n</p><p>Kayes-Wandover, K M, and P C White. 2000. “Steroidogenic Enzyme Gene Expression in the Human Heart.” The Journal of Clinical Endocrinology and Metabolism 85 (7) (July): 2519–25. doi:10.1210/jcem.85.7.6663.\n\n</p><p>Miller, Walter L, and Richard J Auchus. 2011. “The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders.” Endocrine Reviews 32 (1) (February): 81–151. doi:10.1210/er.2010-0013.\n\n</p><p>Rone, Malena B, Jinjiang Fan, and Vassilios Papadopoulos. 2009. “Cholesterol Transport in Steroid Biosynthesis: Role of Protein-Protein Interactions and Implications in Disease States.” Biochimica et Biophysica Acta 1791 (7) (July): 646–58. doi:10.1016/j.bbalip.2009.03.001.\n\n</p><p>Schroeder, F, J F Holland, and L L Bieber. 1971. “Fluorometric Evidence for the Binding of Cholesterol to the Filipin Complex.” The Journal of Antibiotics 24 (12) (December): 846–9.\n\n</p><p>Steer, C. 1984. “Detection of Membrane Cholesterol by Filipin in Isolated Rat Liver Coated Vesicles Is Dependent upon Removal of the Clathrin Coat.” The Journal of Cell Biology 99 (1) (July 1): 315–319. doi:10.1083/jcb.99.1.315.\n\n</p></p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Effect_DownstreamEffect> effect_downstreameffect5_weigth1= new ReferenceIDW<Effect_DownstreamEffect>(effect_downstreameffect5, dataSource, Effect_DownstreamEffect.class,2.0);
effect_downstreameffect5.getDescriptionIDs().set(new DescriptionSection_Structured(effect_downstreameffect5,dataSource,"(Key) Event Essentiality","", effect_downstreameffect5_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);

effect_downstreameffect7 = new Effect_DownstreamEffect(pathway, dataSource);
effect_downstreameffect7.setTitle("Reduction, Testosterone synthesis in Leydig cells");
effect_downstreameffect7.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_LBO.DIMENSION_INDEX, "cellular");
effect_downstreameffect7.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_TAXONOMY.DIMENSION_INDEX, "Rattus norvegicus, Homo sapiens, Mus sp.");
effect_downstreameffect7.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_SEX.DIMENSION_INDEX, "male");
effect_downstreameffect7.getDescriptionIDs().set(new DescriptionSection(effect_downstreameffect7,dataSource,"Description","<div class='description'><h3>Description</h3><p><p><b>Biological state</b>\n\n</p><p>Testosterone is a steroid hormone from the androgen group and is found in humans and other vertebrates. \n\n</p><p><b>Biological compartments</b>\n\n</p><p>In humans and other mammals, testosterone is secreted primarily by the testicles of males and, to a lesser extent, the ovaries of females and other steroidogenic tissues (e.g., brain, adipose). It either acts locally /or is transported to other tissues via blood circulation. Testosterone synthesis takes place within the mitochondria of Leydig cells, the testosterone-producing cells of the testis. It is produced upon stimulation of these cells by Luteinizing hormone (LH) that is secreted in pulses into the peripheral circulation by the pituitary gland in response to Gonadotropin-releasing hormone (GnRH) from the hypothalamus. Testosterone and its aromatized product, estradiol, feed back to the hypothalamus and pituitary gland to suppress transiently LH and thus testosterone production. In response to reduced testosterone levels, GnRH and LH are produced. This negative feedback cycle results in pulsatile secretion of LH followed by pulsatile production of testosterone (Ellis, Desjardins, and Fraser 1983), (Chandrashekar and Bartke 1998).\n\n</p><p><b>General role in biology</b>\n\n</p><p>Testosterone is the principal male sex hormone and an anabolic steroid. Male sexual differentiation depends on testosterone (T), dihydrotestosterone (DHT), and the expression of androgen receptors by target cells (Manson and Carr 2003). During the development secretion of androgens by Leydig cells is essential for masculinization of the foetus (Nef 2000). \n\nThe foetal Leydig cells develop in utero. These cells become competent to produce testosterone in rat  by gestational day (GD) 15.5, with increasing production thereafter. Peak steroidogenic activity is reached just prior to birth, on GD19 (Chen, Ge, and Zirkin 2009). Testosterone secreted by foetal Leydig cells is required for the differentiation of the male urogenital system late in gestation (Huhtaniemi and Pelliniemi 1992). Foetal Leydig cells also play a role in the scrotal descent of the testis through their synthesis of insulin-like growth factor 3 (Insl3), for review see (Nef 2000).\n\n</p><p>In humans, the first morphological sign of testicular differentiation is the formation of testicular cords, which can be seen between 6 and 7 weeks of gestation. Steroid-secreting Leydig cells can be seen in the testis at 8 weeks of gestation. At this period, the concentration of androgens in the testicular tissue and blood starts to rise, peaking at 14-16 weeks of gestation. This increase comes with an increase in the number of Leydig cells for review see (Rouiller-Fabre et al. 2009).\n\n</p><p>Adult Leydig cells, which are distinct from the foetal Leydig cells, form during puberty and supply the testosterone required for the onset of spermatogenesis, among other functions. Distinct stages of adult Leydig cell development have been identified and characterized. The stem Leydig cells are undifferentiated cells that are capable of indefinite self-renewal but also of differentiation to steroidogenic cells. These cells give rise to progenitor Leydig cells,  which proliferate, continue to differentiate, and give rise to the immature Leydig cells. Immature Leydig cells synthesize high levels of testosterone metabolites and develop into  terminally differentiated adult Leydig cells, which  produce high levels of testosterone. With aging, both serum and testicular testosterone concentrations progressively decline, for review see (Nef 2000).\n\n</p><p>Androgens play a crucial role in the development and maintenance of male reproductive and sexual functions.\n\nLow levels of circulating androgens can cause disturbances in male sexual development, resulting in congenital\n\nabnormalities of the male reproductive tract. Later in life, this may cause reduced fertility, sexual dysfunction,\n\ndecreased muscle formation and bone mineralisation, disturbances of fat metabolism, and cognitive\n\ndysfunction. Testosterone levels decrease as a process of ageing: signs and symptoms caused by this decline\n\ncan be considered a normal part of ageing.\n\n</p></p></div><div class='references'><h3>References</h3><p><p>Chandrashekar, V, and A Bartke. 1998. “The Role of Growth Hormone in the Control of Gonadotropin Secretion in Adult Male Rats.” Endocrinology 139 (3) (March): 1067–74. doi:10.1210/endo.139.3.5816.\n\n</p><p>Ellis, G B, C Desjardins, and H M Fraser. 1983. “Control of Pulsatile LH Release in Male Rats.” Neuroendocrinology 37 (3) (September): 177–83.\n\nHuhtaniemi, I, and L J Pelliniemi. 1992. “Fetal Leydig Cells: Cellular Origin, Morphology, Life Span, and Special Functional Features.” Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 201 (2) (November): 125–40.\n\n</p><p>Manson, Jeanne M, and Michael C Carr. 2003. “Molecular Epidemiology of Hypospadias: Review of Genetic and Environmental Risk Factors.” Birth Defects Research. Part A, Clinical and Molecular Teratology 67 (10) (October): 825–36. doi:10.1002/bdra.10084.\n\n</p><p>Nef, S. 2000. “Hormones in Male Sexual Development.” Genes &amp; Development 14 (24) (December 15): 3075–3086. doi:10.1101/gad.843800.\n\n</p><p>Rouiller-Fabre, Virginie, Vincent Muczynski, Romain Lambrot, Charlotte Lécureuil, Hervé Coffigny, Catherine Pairault, Delphine Moison, et al. 2009. “Ontogenesis of Testicular Function in Humans.” Folia Histochemica et Cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 47 (5) (January): S19–24. doi:10.2478/v10042-009-0065-4.\n\n</p></p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Effect_DownstreamEffect> effect_downstreameffect7_weigth1= new ReferenceIDW<Effect_DownstreamEffect>(effect_downstreameffect7, dataSource, Effect_DownstreamEffect.class,2.0);
effect_downstreameffect7.getDescriptionIDs().set(new DescriptionSection_Structured(effect_downstreameffect7,dataSource,"(Key) Event Essentiality","", effect_downstreameffect7_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);

effect_downstreameffect9 = new Effect_DownstreamEffect(pathway, dataSource);
effect_downstreameffect9.setTitle("Reduction, testosterone level");
effect_downstreameffect9.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_LBO.DIMENSION_INDEX, "tissue");
effect_downstreameffect9.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_TAXONOMY.DIMENSION_INDEX, "Homo sapiens, Rattus norvegicus, Mus musculus");
effect_downstreameffect9.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_SEX.DIMENSION_INDEX, "male");
effect_downstreameffect9.getDescriptionIDs().set(new DescriptionSection(effect_downstreameffect9,dataSource,"Description","<div class='description'><h3>Description</h3><p><p><strong>Biological state</strong></p>\n\n<p>Testosterone (T) is a steroid hormone from the androgen group. T serves as a substrate for two metabolic pathways that produce antagonistic sex steroids.</p>\n\n<p><strong>Biological compartments</strong></p>\n\n<p>Testosterone is synthesized by the gonads and other steroidogenic tissues (e.g., brain, adipose), acts locally and/or is transported to other tissues via blood circulation. Leydig cells are the testosterone-producing cells of the testis.</p>\n\n<p><strong>General role in biology</strong></p>\n\n<p>Androgens, the main male sex steroids, are the critical factors responsible for the development of the male phenotype during embryogenesis and for the achievement of sexual maturation at puberty. In adulthood, androgens remain essential for the maintenance of male reproductive function and behaviour. Apart from their effects on reproduction, androgens affect a wide variety of non-reproductive tissues such as skin, bone, muscle, and brain (Heemers, Verhoeven, &amp; Swinnen, 2006). Androgens, principally T and 5&alpha;-dihydrotestosterone (DHT), exert most of their effects by interacting with a specific receptor, the androgen receptor (AR), for review see (Murashima, Kishigami, Thomson, &amp; Yamada, 2015). On the one hand, testosterone can be reduced by 5&alpha;-reductase to produce 5&alpha; dihydrotestosterone (DHT). On the other hand, testosterone can be aromatized to generate estrogens. Testosterone effects can also be classified by the age of usual occurrence, postnatal effects in both males and females are mostly dependent on the levels and duration of circulating free testosterone.</p>\n\n</p></div><div class='references'><h3>References</h3><p><p>Heemers, H. V, Verhoeven, G., &amp; Swinnen, J. V. (2006). Androgen activation of the sterol regulatory element-binding protein pathway: Current insights. Molecular Endocrinology (Baltimore, Md.), 20(10), 2265&ndash;77. doi:10.1210/me.2005-0479</p>\n\n<p>Murashima, A., Kishigami, S., Thomson, A., &amp; Yamada, G. (2015). Androgens and mammalian male reproductive tract development. Biochimica et Biophysica Acta, 1849(2), 163&ndash;170. doi:10.1016/j.bbagrm.2014.05.020</p>\n\n<p>Paduch, D. A., Brannigan, R. E., Fuchs, E. F., Kim, E. D., Marmar, J. L., &amp; Sandlow, J. I. (2014). The laboratory diagnosis of testosterone deficiency. Urology, 83(5), 980&ndash;8. doi:10.1016/j.urology.2013.12.024</p>\n\n<p>Taieb, J., Mathian, B., Millot, F., Patricot, M.-C., Mathieu, E., Queyrel, N., &hellip; Boudou, P. (2003). Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clinical Chemistry, 49(8), 1381&ndash;95.</p>\n\n</p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Effect_DownstreamEffect> effect_downstreameffect9_weigth1= new ReferenceIDW<Effect_DownstreamEffect>(effect_downstreameffect9, dataSource, Effect_DownstreamEffect.class,2.0);
effect_downstreameffect9.getDescriptionIDs().set(new DescriptionSection_Structured(effect_downstreameffect9,dataSource,"(Key) Event Essentiality","", effect_downstreameffect9_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);

effect_downstreameffect12 = new Effect_DownstreamEffect(pathway, dataSource);
effect_downstreameffect12.setTitle("Decrease, Translocator protein (TSPO)");
effect_downstreameffect12.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_LBO.DIMENSION_INDEX, "cellular");
effect_downstreameffect12.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_TAXONOMY.DIMENSION_INDEX, "Homo sapiens, Rattus norvegicus, Mus musculus");
effect_downstreameffect12.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_SEX.DIMENSION_INDEX, "male");
effect_downstreameffect12.getDescriptionIDs().set(new DescriptionSection(effect_downstreameffect12,dataSource,"Description","<div class='description'><h3>Description</h3><p><p><strong>Biological state</strong></p>\n\n<p>Translocator protein (TSPO), previously known as the peripheral benzodiazepine receptor (PBR), is a mitochondrial outer membrane protein implicated in cholesterol import to the inner mitochondrial membrane (Besman et al. 1989).</p>\n\n<p><strong>Biological compartments</strong></p>\n\n<p>The TSPO is present in virtually all mammalian peripheral tissues (Zisterer and Williams 1997), however highly prominent TSPO protein expression has been identified in steroidogenic tissues (R. R. Anholt et al. 1985), (Wang, Fan, and Papadopoulos 2012). The presence of TSOP has been confirmed in Leydig and Sertoli cells (Morohaku, Phuong, and Selvaraj 2013), granulosa cells (Amsterdam and Suh 1991) and to a lesser extent in thecal cells (Morohaku, Phuong, and Selvaraj 2013). In subcellular fractions, binding sites for the TSOP have been identified to be present in the outer mitochondrial membrane (OMM) (R. R. Anholt et al. 1985), (R. Anholt et al. 1986). Transcriptional regulation of TSPO genes has been examined and recently reviewed (Morohaku, Phuong, and Selvaraj 2013).</p>\n\n<p><strong>General role in biology: regulation of lipid transport</strong></p>\n\n<p>TSPO mediates the delivery of the substrate cholesterol to the inner mitochondrial side chain cleavage enzyme P450scc (Besman et al. 1989). TSPO ligands stimulate steroidogenesis and induce cholesterol movement from the outer mitochondrial membrane (OMM) to the inner mitochondrial membrane (IMM) (Besman et al. 1989).</p>\n\n</p></div><div class='references'><h3>References</h3><p><p>Amsterdam, A. &amp; Suh, B.S., 1991. An inducible functional peripheral benzodiazepine receptor in mitochondria of steroidogenic granulosa cells. Endocrinology, 129(1), pp.503&ndash;10.</p>\n\n<p>Anholt, R. et al., 1986. The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J. Biol. Chem., 261(2), pp.576&ndash;583.</p>\n\n<p>Anholt, R.R. et al., 1985. Peripheral-type benzodiazepine receptors: autoradiographic localization in whole-body sections of neonatal rats. The Journal of pharmacology and experimental therapeutics, 233(2), pp.517&ndash;26.</p>\n\n<p>Besman, M.J. et al., 1989. Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proceedings of the National Academy of Sciences of the United States of America, 86(13), pp.4897&ndash;901.</p>\n\n<p>Lacap&egrave;re, J.J. &amp; Papadopoulos, V., 2003. Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids, 68(7-8), pp.569&ndash;85.</p>\n\n<p>Morohaku, K. et al., 2014. Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology, 155(1), pp.89&ndash;97. Morohaku, K., Phuong, N.S. &amp; Selvaraj, V., 2013. Developmental expression of translocator protein/peripheral benzodiazepine receptor in reproductive tissues. W. Yan, ed. PloS one, 8(9), p.e74509.</p>\n\n<p>Papadopoulos, V. et al., 1997. Targeted disruption of the peripheral-type benzodiazepine receptor gene inhibits steroidogenesis in the R2C Leydig tumor cell line. The Journal of biological chemistry, 272(51), pp.32129&ndash;35.</p>\n\n<p>Tu, L.N. et al., 2014. Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis. The Journal of biological chemistry, 289(40), pp.27444&ndash;54.</p>\n\n<p>Wang, H.-J., Fan, J. &amp; Papadopoulos, V., 2012. Translocator protein (Tspo) gene promoter-driven green fluorescent protein synthesis in transgenic mice: an in vivo model to study Tspo transcription. Cell and tissue research, 350(2), pp.261&ndash;75.</p>\n\n<p>Yeliseev, A.A., Krueger, K.E. &amp; Kaplan, S., 1997. A mammalian mitochondrial drug receptor functions as a bacterial &ldquo;oxygen&rdquo; sensor. Proceedings of the National Academy of Sciences of the United States of America, 94(10), pp.5101&ndash;6. Zisterer, D.M. &amp; Williams, D.C., 1997. Peripheral-type benzodiazepine receptors. General pharmacology, 29(3), pp.305&ndash;14.</p>\n\n</p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Effect_DownstreamEffect> effect_downstreameffect12_weigth1= new ReferenceIDW<Effect_DownstreamEffect>(effect_downstreameffect12, dataSource, Effect_DownstreamEffect.class,1.0);
effect_downstreameffect12.getDescriptionIDs().set(new DescriptionSection_Structured(effect_downstreameffect12,dataSource,"(Key) Event Essentiality","", effect_downstreameffect12_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);

effect_downstreameffect14 = new Effect_DownstreamEffect(pathway, dataSource);
effect_downstreameffect14.setTitle("Malformation, Male reproductive tract");
effect_downstreameffect14.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_LBO.DIMENSION_INDEX, "organ");
effect_downstreameffect14.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_TAXONOMY.DIMENSION_INDEX, "Homo sapiens, Rattus norvegicus");
effect_downstreameffect14.getCoordinates().setValue(DefaultEffectopediaObjects.DEFAULT_SEX.DIMENSION_INDEX, "male");
effect_downstreameffect14.getDescriptionIDs().set(new DescriptionSection(effect_downstreameffect14,dataSource,"Description","<div class='description'><h3>Description</h3><p><p><strong>Biological state</strong></p>\n\n<p><strong>Male reproductive tract malformations</strong> (congenital malformation of male genitalia) comprise any physical abnormality of the male internal or external genitalia present at birth. Some result from excessive or deficient androgen effect, others result from teratogenic effects, or are associated with anomalies of other parts of the body in a recognizable pattern (i.e., a syndrome). The cause of many of these birth defects is unknown.</p>\n\n<p><strong>Hypospadias</strong> is a defect of the urogenital system, a malformation in which the urethra opens on the underside of the penis instead of the tip. It results from an incomplete closure of the urethral folds, leaving a split on the penis (Kalfa, Philibert, and Sultan 2009). When the urethra opens to the glans or corona of the penis, it is called distal, whereas opening to the shaft or penoscrotal area defines hypospadias as proximal. Androgens regulate the masculinization of external genitalia. Therefore any defects in androgen biosynthesis, metabolism or action during foetal development can cause hypospadias. Gene defects causing disorders of testicular differentiation, conversion of testosterone to dihydrotestosterone or mutations in the androgen receptor can also result in hypospadias (Kalfa et al. 2008). In about 20% of patients with isolated hypospadias there are signs of endocrine abnormalities by the time of diagnosis (Rey et al. 2005). The majority of hypospadias are believed to have a multifactorial etiology, although a small percentage do result from single gene mutations (Baskin, Himes, and Colborn 2001). The only treatment of hypospadias is surgery, thus, prevention is imperative.</p>\n\n<p><br />\n\n<strong>Biological compartments</strong>: reproductive system</p>\n\n</p></div><div class='references'><h3>References</h3><p><p><br />\n\nArbuckle, Tye E, Russ Hauser, Shanna H Swan, Catherine S Mao, Matthew P Longnecker, Katharina M Main, Robin M Whyatt, et al. 2008. &ldquo;Meeting Report: Measuring Endocrine-Sensitive Endpoints within the First Years of Life.&rdquo; Environmental Health Perspectives 116 (7) (July): 948&ndash;51. doi:10.1289/ehp.11226.</p>\n\n<p>Barrett, Emily S, Lauren E Parlett, J Bruce Redmon, and Shanna H Swan. 2014. &ldquo;Evidence for Sexually Dimorphic Associations between Maternal Characteristics and Anogenital Distance, a Marker of Reproductive Development.&rdquo; American Journal of Epidemiology 179 (1) (January 1): 57&ndash;66. doi:10.1093/aje/kwt220.</p>\n\n<p>Baskin, L S, K Himes, and T Colborn. 2001. &ldquo;Hypospadias and Endocrine Disruption: Is There a Connection?&rdquo; Environmental Health Perspectives 109 (11) (November): 1175&ndash;83.</p>\n\n<p>Bowman, Christopher J, Norman J Barlow, Katie J Turner, Duncan G Wallace, and Paul M D Foster. 2003. &ldquo;Effects of in Utero Exposure to Finasteride on Androgen-Dependent Reproductive Development in the Male Rat.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 74 (2) (August): 393&ndash;406. doi:10.1093/toxsci/kfg128.</p>\n\n<p>Dean, Afshan, and Richard M Sharpe. 2013. &ldquo;Clinical Review: Anogenital Distance or Digit Length Ratio as Measures of Fetal Androgen Exposure: Relationship to Male Reproductive Development and Its Disorders.&rdquo; The Journal of Clinical Endocrinology and Metabolism 98 (6) (June): 2230&ndash;8. doi:10.1210/jc.2012-4057.</p>\n\n<p>Gray, L E, J Ostby, J Furr, C J Wolf, C Lambright, L Parks, D N Veeramachaneni, et al. 2001. &ldquo;Effects of Environmental Antiandrogens on Reproductive Development in Experimental Animals.&rdquo; Human Reproduction Update 7 (3): 248&ndash;64.</p>\n\n<p>Hayes, Tyrone B, Atif Collins, Melissa Lee, Magdelena Mendoza, Nigel Noriega, A Ali Stuart, and Aaron Vonk. 2002. &ldquo;Hermaphroditic, Demasculinized Frogs after Exposure to the Herbicide Atrazine at Low Ecologically Relevant Doses.&rdquo; Proceedings of the National Academy of Sciences of the United States of America 99 (8) (April 16): 5476&ndash;80. doi:10.1073/pnas.082121499.</p>\n\n<p>Howdeshell, Kembra L, Johnathan Furr, Christy R Lambright, Cynthia V Rider, Vickie S Wilson, and L Earl Gray. 2007. &ldquo;Cumulative Effects of Dibutyl Phthalate and Diethylhexyl Phthalate on Male Rat Reproductive Tract Development: Altered Fetal Steroid Hormones and Genes.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 99 (1) (September): 190&ndash;202. doi:10.1093/toxsci/kfm069.</p>\n\n<p>Kalfa, Nicolas, Benchun Liu, Ophir Klein, Ming-Hsieh Wang, Mei Cao, and Laurence S Baskin. 2008. &ldquo;Genomic Variants of ATF3 in Patients with Hypospadias.&rdquo; The Journal of Urology 180 (5) (November): 2183&ndash;8; discussion 2188. doi:10.1016/j.juro.2008.07.066.</p>\n\n<p>Kalfa, Nicolas, Pascal Philibert, and Charles Sultan. 2009. &ldquo;Is Hypospadias a Genetic, Endocrine or Environmental Disease, or Still an Unexplained Malformation?&rdquo; International Journal of Andrology 32 (3) (June): 187&ndash;97. doi:10.1111/j.1365-2605.2008.00899.x.</p>\n\n<p>Macleod, D J, R M Sharpe, M Welsh, M Fisken, H M Scott, G R Hutchison, A J Drake, and S van den Driesche. 2010. &ldquo;Androgen Action in the Masculinization Programming Window and Development of Male Reproductive Organs.&rdquo; International Journal of Andrology 33 (2) (April): 279&ndash;87. doi:10.1111/j.1365-2605.2009.01005.x.</p>\n\n<p>Manson, Jeanne M, and Michael C Carr. 2003. &ldquo;Molecular Epidemiology of Hypospadias: Review of Genetic and Environmental Risk Factors.&rdquo; Birth Defects Research. Part A, Clinical and Molecular Teratology 67 (10) (October): 825&ndash;36. doi:10.1002/bdra.10084.</p>\n\n<p>McIntyre, B S, N J Barlow, and P M Foster. 2001. &ldquo;Androgen-Mediated Development in Male Rat Offspring Exposed to Flutamide in Utero: Permanence and Correlation of Early Postnatal Changes in Anogenital Distance and Nipple Retention with Malformations in Androgen-Dependent Tissues.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 62 (2) (August): 236&ndash;49.</p>\n\n<p>Mendiola, Jaime, Manuela Roca, Lidia M&iacute;nguez-Alarc&oacute;n, Maria-Pilar Mira-Escolano, Jos&eacute; J L&oacute;pez-Esp&iacute;n, Emily S Barrett, Shanna H Swan, and Alberto M Torres-Cantero. 2012. &ldquo;Anogenital Distance Is Related to Ovarian Follicular Number in Young Spanish Women: A Cross-Sectional Study.&rdquo; Environmental Health : A Global Access Science Source 11 (January): 90. doi:10.1186/1476-069X-11-90.</p>\n\n<p>OECD. 2012. Test No. 443: Extended One-Generation Reproductive Toxicity Study. OECD Guidelines for the Testing of Chemicals, Section 4. OECD Publishing. doi:10.1787/9789264185371-en.</p>\n\n<p>Rey, Rodolfo A, Ethel Codner, Germ&aacute;n I&ntilde;&iacute;guez, Patricia Bedecarr&aacute;s, Romina Trigo, Cecilia Okuma, Silvia Gottlieb, Ignacio Bergad&aacute;, Stella M Campo, and Fernando G Cassorla. 2005. &ldquo;Low Risk of Impaired Testicular Sertoli and Leydig Cell Functions in Boys with Isolated Hypospadias.&rdquo; The Journal of Clinical Endocrinology and Metabolism 90 (11) (November): 6035&ndash;40. doi:10.1210/jc.2005-1306.</p>\n\n<p>Wolf, C., C. Lambright, P. Mann, M. Price, R. L. Cooper, J. Ostby, and L. E. Gray. 1999. &ldquo;Administration of Potentially Antiandrogenic Pesticides (procymidone, Linuron, Iprodione, Chlozolinate, P,p&rsquo;-DDE, and Ketoconazole) and Toxic Substances (dibutyl- and Diethylhexyl Phthalate, PCB 169, and Ethane Dimethane Sulphonate) during Sexual Differen.&rdquo; Toxicology and Industrial Health 15 (1-2) (February 1): 94&ndash;118. doi:10.1177/074823379901500109.</p>\n\n</p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Effect_DownstreamEffect> effect_downstreameffect14_weigth1= new ReferenceIDW<Effect_DownstreamEffect>(effect_downstreameffect14, dataSource, Effect_DownstreamEffect.class,0.0);
effect_downstreameffect14.getDescriptionIDs().set(new DescriptionSection_Structured(effect_downstreameffect14,dataSource,"(Key) Event Essentiality","", effect_downstreameffect14_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);

link_effecttoeffect6 = new Link_EffectToEffect(pathway, dataSource,effect_downstreameffect4, effect_downstreameffect5);
link_effecttoeffect6.setLinkType(LinkType.DIRECT);link_effecttoeffect6.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect6,dataSource,"Description","<div class='description'><h3>Description</h3><p><p>Steroidogenic acute regulatory protein (StAR) mediates the cholesterol transport from the outer to the inner mitochondrial membrane, where it undergoes side chain cleavage by cytochrome P-450 enzyme (P450scc) that yields the steroid precursor, pregnenolone (Besman et al. 1989). The cholesterol transfer within the mitochondria is the rate-limiting step in the production of steroid hormones. Therefore reduced amount/activity of the StAR impairs the cholesterol delivery that is necessary for the hormone biosynthesis.</p>\n\n</p></div><div class='references'><h3>References</h3><p><p>Barlow, Norman J, Suzanne L Phillips, Duncan G Wallace, Madhabananda Sar, Kevin W Gaido, and Paul M D Foster. 2003. &ldquo;Quantitative Changes in Gene Expression in Fetal Rat Testes Following Exposure to Di(n-Butyl) Phthalate.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 73 (2) (June): 431&ndash;41. doi:10.1093/toxsci/kfg087.</p>\n\n<p>Besman, M J, K Yanagibashi, T D Lee, M Kawamura, P F Hall, and J E Shively. 1989. &ldquo;Identification of Des-(Gly-Ile)-Endozepine as an Effector of Corticotropin-Dependent Adrenal Steroidogenesis: Stimulation of Cholesterol Delivery Is Mediated by the Peripheral Benzodiazepine Receptor.&rdquo; Proceedings of the National Academy of Sciences of the United States of America 86 (13) (July): 4897&ndash;901.</p>\n\n<p>Borch, Julie, Stine Broeng Metzdorff, Anne Marie Vinggaard, Leon Brokken, and Majken Dalgaard. 2006. &ldquo;Mechanisms Underlying the Anti-Androgenic Effects of Diethylhexyl Phthalate in Fetal Rat Testis.&rdquo; Toxicology 223 (1-2) (June 1): 144&ndash;55. doi:10.1016/j.tox.2006.03.015.</p>\n\n<p>Johnson, Kamin J, Erin N McDowell, Megan P Viereck, and Jessie Q Xia. 2011. &ldquo;Species-Specific Dibutyl Phthalate Fetal Testis Endocrine Disruption Correlates with Inhibition of SREBP2-Dependent Gene Expression Pathways.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 120 (2) (April): 460&ndash;74. doi:10.1093/toxsci/kfr020.</p>\n\n<p>Lin, D, T Sugawara, J F Strauss, B J Clark, D M Stocco, P Saenger, A Rogol, and W L Miller. 1995. &ldquo;Role of Steroidogenic Acute Regulatory Protein in Adrenal and Gonadal Steroidogenesis.&rdquo; Science (New York, N.Y.) 267 (5205) (March 24): 1828&ndash;31.</p>\n\n<p>Miller, Walter L, and Richard J Auchus. 2011. &ldquo;The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders.&rdquo; Endocrine Reviews 32 (1) (February): 81&ndash;151. doi:10.1210/er.2010-0013.</p>\n\n<p>Shultz, V. D. 2001. &ldquo;Altered Gene Profiles in Fetal Rat Testes after in Utero Exposure to Di(n-Butyl) Phthalate.&rdquo; Toxicological Sciences 64 (2) (December 1): 233&ndash;242. doi:10.1093/toxsci/64.2.233.</p>\n\n<p>Svechnikov, Konstantin, Irina Svechnikova, and Olle S&ouml;der. 2008. &ldquo;Inhibitory Effects of Mono-Ethylhexyl Phthalate on Steroidogenesis in Immature and Adult Rat Leydig Cells in Vitro.&rdquo; Reproductive Toxicology (Elmsford, N.Y.) 25 (4) (August): 485&ndash;90. doi:10.1016/j.reprotox.2008.05.057.</p>\n\n<p>Thompson, Christopher J, Susan M Ross, and Kevin W Gaido. 2004. &ldquo;Di(n-Butyl) Phthalate Impairs Cholesterol Transport and Steroidogenesis in the Fetal Rat Testis through a Rapid and Reversible Mechanism.&rdquo; Endocrinology 145 (3) (March): 1227&ndash;37. doi:10.1210/en.2003-1475.</p>\n\n<p>Thompson, Christopher J, Susan M Ross, Janan Hensley, Kejun Liu, Susanna C Heinze, S Stanley Young, and Kevin W Gaido. 2005. &ldquo;Differential Steroidogenic Gene Expression in the Fetal Adrenal Gland versus the Testis and Rapid and Dynamic Response of the Fetal Testis to Di(n-Butyl) Phthalate.&rdquo; Biology of Reproduction 73 (5) (November): 908&ndash;17. doi:10.1095/biolreprod.105.042382.</p>\n\n</p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Link_EffectToEffect> link_effecttoeffect6_weigth1= new ReferenceIDW<Link_EffectToEffect>(link_effecttoeffect6, dataSource, Link_EffectToEffect.class,2.0);
link_effecttoeffect6.getDescriptionIDs().set(new DescriptionSection_Structured(link_effecttoeffect6,dataSource,"(Key) Event Relationship Weight of Evidence","<div class='biological-plausibility'><h3>Biological Plausibility</h3><p><p>The first step in steroidogenesis takes place within mitochondria. StAR facilitates the movement of cholesterol from the outer mitochondrial membrane (OMM) to the inner mitochondrial membrane (IMM) for steroidogenesis [reviewed in (Miller and Auchus 2011)]. It is primarily present in steroid-producing cells, including theca cells and luteal cells in the ovary, Leydig cells in the testis and cells in the adrenal cortex.</p>\n\n</p></div><div class='empirical-support-for-linkage'><h3>Empirical Support for Linkage</h3><p><p>Down-regulation of StAR and impaired steroidogenesis was reported upon exposure to phthalates i.a. (Barlow et al. 2003), (Borch et al. 2006), for details see Table 1.</p>\n\n<table class=\"wikitable\" id=\"Event436\">\n\n	<tbody>\n\n		<tr>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p><strong>KE: StAR, decrease</strong></p>\n\n			</td>\n\n			<td>\n\n			<p><strong>KE: Cholesterol transport, decrease</strong></p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Compound</p>\n\n			</td>\n\n			<td>\n\n			<p>Species</p>\n\n			</td>\n\n			<td>\n\n			<p>Effect level</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>Details</p>\n\n			</td>\n\n			<td>\n\n			<p>References</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=500 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>mRNA StAR decrease (by ~34%)</p>\n\n			</td>\n\n			<td>\n\n			<p>reduced Leydig cell lipid content</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>(Barlow et al. 2003)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=500 mg/kg/day (GD12-19)</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>decrease uptake of cholesterol Leydig cell mitochondria</p>\n\n			</td>\n\n			<td>\n\n			<p>decreased testosterone, decreased expression of scavenger receptor B1, P450(SCC), steroidogenic acute regulatory protein, and cytochrome p450c17</p>\n\n			</td>\n\n			<td>\n\n			<p>(Thompson, Ross, and Gaido 2004)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=500 mg/kg</p>\n\n			</td>\n\n			<td>\n\n			<p>mRNA and protein StAR decrease</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>1 dose, Time course analysis (0,5,1,2,3,6,12,18, 24h killed at GD), decreased testosterone in foetal testis</p>\n\n			</td>\n\n			<td>\n\n			<p>(Thompson et al. 2005)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=300&nbsp;mg/ kg/day</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>mRNA StAR decrease</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>dose-dependently reduced StAR, TSOP mRNA (GD 21 testes), also on protein levels in Leydig cells</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Borch et al. 2006)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=500 mg/kg/day, (GD12 to 21)</p>\n\n			</td>\n\n			<td>\n\n			<p>mRNA StAR decrease</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>Testes examined GD 16, 19, and 21, cytochrome P450 side chain cleavage, cytochrome P450c17, decrease.</p>\n\n			<p>Testicular testosterone and androstenedione decreased (GD 19 and 21)</p>\n\n			</td>\n\n			<td>\n\n			<p>(Shultz 2001)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (MEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=250&nbsp;&mu;M</p>\n\n			</td>\n\n			<td>\n\n			<p>protein StAR decrease (immature and adult Leydig cells)</p>\n\n			</td>\n\n			<td>\n\n			<p>cholesterol transport, decrease (into the mitochondria of immature and adult Leydig cells</p>\n\n			</td>\n\n			<td>\n\n			<p>decreased testosterone by approximately 60%, in vitro ( immature and adult Leydig cells)</p>\n\n			</td>\n\n			<td>\n\n			<p>(Svechnikov, Svechnikova, and S&ouml;der 2008)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=500 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>mRNA StAR decrease</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>GD 12 -20, examinations on GD20</p>\n\n			</td>\n\n			<td>\n\n			<p>(Johnson et al. 2011)</p>\n\n			</td>\n\n		</tr>\n\n	</tbody>\n\n</table>\n\n<p>Table 1 Summary table of empirical support for this KER. LOEC-lowest effect concentration, LOEL- lowest observed effect level, Dibutyl phthalate (DBP), Di-2-ethylhexyl phthalate (DEHP), mono(2-ethylhexyl) phthalate (MEHP).</p>\n\n</p></div><div class='uncertainties-or-inconsistencies'><h3>Uncertainties or Inconsistencies</h3><p><p>Some steroidogenesis is independent of StAR; when nonsteroidogenic cells are transfected with the P450scc system, they convert cholesterol to pregnenolone at about 14% of the StAR-induced rate (Lin et al. 1995). The mechanism of StAR-independent steroidogenesis is unclear (Miller and Auchus 2011). Johnson et al proposed the involvment of sterol regulatory element&ndash;binding protein (SREBP) in phthalate mediated disruption of steroidogenesis. Their study showed lipid metabolism pathways transcriptionally regulated by SREBP were inhibited in the rat but induced in the mouse, and this differential species response corresponded with repression of the steroidogenic pathway. In rats exposed to 100 or 500 mg/kg DBP from gestational days (GD) 16 to 20, a correlation was observed between GD20 testis steroidogenic inhibition and reductions of testis cholesterol synthesis endpoints including testis total cholesterol levels (Johnson et al. 2011).</p>\n\n</p></div>", link_effecttoeffect6_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);
link_effecttoeffect6.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect6,dataSource,"Evidence Supporting Taxonomic Applicability","<p>Rat see Table 1.</p>\n\n").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 2);
link_effecttoeffect6.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect6,dataSource,"Quantitative Understanding","<p>Evidence support: Unspecified</p><p></p>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 3);

link_effecttoeffect8 = new Link_EffectToEffect(pathway, dataSource,effect_downstreameffect5, effect_downstreameffect7);
link_effecttoeffect8.setLinkType(LinkType.DIRECT);link_effecttoeffect8.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect8,dataSource,"Description","<div class='description'><h3>Description</h3><p><p>Production of steroid hormones depends on the availability of cholesterol in the mitochondrial matrix. A decreased amount of cholesterol inside the mitochondria (e. g by decreased expression of enzymes that transport cholesterol like StAR or TSOP) means diminished substrate for hormone (testosterone) production in testes.</p>\n\n</p></div><div class='references'><h3>References</h3><p><p>Barlow, N. J., Phillips, S. L., Wallace, D. G., Sar, M., Gaido, K. W., &amp; Foster, P. M. D. (2003). Quantitative changes in gene expression in fetal rat testes following exposure to di(n-butyl) phthalate. Toxicological Sciences : An Official Journal of the Society of Toxicology, 73(2), 431&ndash;41. doi:10.1093/toxsci/kfg087</p>\n\n<p>Boberg, J., Metzdorff, S., Wortziger, R., Axelstad, M., Brokken, L., Vinggaard, A. M., &hellip; Nellemann, C. (2008). Impact of diisobutyl phthalate and other PPAR agonists on steroidogenesis and plasma insulin and leptin levels in fetal rats. Toxicology, 250(2-3), 75&ndash;81. doi:10.1016/j.tox.2008.05.020</p>\n\n<p>Borch, J., Ladefoged, O., Hass, U., &amp; Vinggaard, A. M. (2004). Steroidogenesis in fetal male rats is reduced by DEHP and DINP, but endocrine effects of DEHP are not modulated by DEHA in fetal, prepubertal and adult male rats. Reproductive Toxicology (Elmsford, N.Y.), 18(1), 53&ndash;61. doi:10.1016/j.reprotox.2003.10.011</p>\n\n<p>Borch, J., Metzdorff, S. B., Vinggaard, A. M., Brokken, L., &amp; Dalgaard, M. (2006). Mechanisms underlying the anti-androgenic effects of diethylhexyl phthalate in fetal rat testis. Toxicology, 223(1-2), 144&ndash;55. doi:10.1016/j.tox.2006.03.015</p>\n\n<p>Chauvign&eacute;, F., Plummer, S., Lesn&eacute;, L., Cravedi, J.-P., Dejucq-Rainsford, N., Fostier, A., &amp; J&eacute;gou, B. (2011). Mono-(2-ethylhexyl) phthalate directly alters the expression of Leydig cell genes and CYP17 lyase activity in cultured rat fetal testis. PloS One, 6(11), e27172. doi:10.1371/journal.pone.0027172</p>\n\n<p>Furr, J. R., Lambright, C. S., Wilson, V. S., Foster, P. M., &amp; Gray, L. E. (2014). A short-term in vivo screen using fetal testosterone production, a key event in the phthalate adverse outcome pathway, to predict disruption of sexual differentiation. Toxicological Sciences : An Official Journal of the Society of Toxicology, 140(2), 403&ndash;24. doi:10.1093/toxsci/kfu081</p>\n\n<p>Gazouli, M. (2002). Effect of Peroxisome Proliferators on Leydig Cell Peripheral-Type Benzodiazepine Receptor Gene Expression, Hormone-Stimulated Cholesterol Transport, and Steroidogenesis: Role of the Peroxisome Proliferator-Activator Receptor . Endocrinology, 143(7), 2571&ndash;2583. doi:10.1210/en.143.7.2571</p>\n\n<p>Hauet, T., Yao, Z.-X., Bose, H. S., Wall, C. T., Han, Z., Li, W., &hellip; Papadopoulos, V. (2005). Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into leydig cell mitochondria. Molecular Endocrinology (Baltimore, Md.), 19(2), 540&ndash;54. doi:10.1210/me.2004-0307</p>\n\n<p>Johnson, K. J., McDowell, E. N., Viereck, M. P., &amp; Xia, J. Q. (2011). Species-specific dibutyl phthalate fetal testis endocrine disruption correlates with inhibition of SREBP2-dependent gene expression pathways. Toxicological Sciences : An Official Journal of the Society of Toxicology, 120(2), 460&ndash;74. doi:10.1093/toxsci/kfr020</p>\n\n<p>Lehmann, K. P., Phillips, S., Sar, M., Foster, P. M. D., &amp; Gaido, K. W. (2004). Dose-dependent alterations in gene expression and testosterone synthesis in the fetal testes of male rats exposed to di (n-butyl) phthalate. Toxicological Sciences : An Official Journal of the Society of Toxicology, 81(1), 60&ndash;8. doi:10.1093/toxsci/kfh169</p>\n\n<p>Li, Y., Ramdhan, D. H., Naito, H., Yamagishi, N., Ito, Y., Hayashi, Y., &hellip; Nakajima, T. (2011). Ammonium perfluorooctanoate may cause testosterone reduction by adversely affecting testis in relation to PPAR&alpha;. Toxicology Letters, 205(3), 265&ndash;72. doi:10.1016/j.toxlet.2011.06.015 Miller, W. L. (2007). Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter. Biochimica et Biophysica Acta, 1771(6), 663&ndash;76. doi:10.1016/j.bbalip.2007.02.012</p>\n\n<p>Parks, L. G. (2000). The Plasticizer Diethylhexyl Phthalate Induces Malformations by Decreasing Fetal Testosterone Synthesis during Sexual Differentiation in the Male Rat. Toxicological Sciences, 58(2), 339&ndash;349. doi:10.1093/toxsci/58.2.339</p>\n\n<p>Payne, A. H., &amp; Hales, D. B. (2013). Overview of Steroidogenic Enzymes in the Pathway from Cholesterol to Active Steroid Hormones. Endocrine Reviews. Stocco, D. M. (2001). StAR protein and the regulation of steroid hormone biosynthesis. Annual Review of Physiology, 63, 193&ndash;213. doi:10.1146/annurev.physiol.63.1.193</p>\n\n<p>Svechnikov, K., Svechnikova, I., &amp; S&ouml;der, O. (2008). Inhibitory effects of mono-ethylhexyl phthalate on steroidogenesis in immature and adult rat Leydig cells in vitro. Reproductive Toxicology (Elmsford, N.Y.), 25(4), 485&ndash;90. doi:10.1016/j.reprotox.2008.05.057</p>\n\n<p>Thompson, C. J., Ross, S. M., &amp; Gaido, K. W. (2004). Di(n-butyl) phthalate impairs cholesterol transport and steroidogenesis in the fetal rat testis through a rapid and reversible mechanism. Endocrinology, 145(3), 1227&ndash;37. doi:10.1210/en.2003-1475</p>\n\n<p>Thompson, C. J., Ross, S. M., Hensley, J., Liu, K., Heinze, S. C., Young, S. S., &amp; Gaido, K. W. (2005). Differential steroidogenic gene expression in the fetal adrenal gland versus the testis and rapid and dynamic response of the fetal testis to di(n-butyl) phthalate. Biology of Reproduction, 73(5), 908&ndash;17. doi:10.1095/biolreprod.105.042382</p>\n\n<p>Wilson, V. S., Lambright, C., Furr, J., Ostby, J., Wood, C., Held, G., &amp; Gray, L. E. (2004). Phthalate ester-induced gubernacular lesions are associated with reduced insl3 gene expression in the fetal rat testis. Toxicology Letters, 146(3), 207&ndash;15.</p>\n\n</p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Link_EffectToEffect> link_effecttoeffect8_weigth1= new ReferenceIDW<Link_EffectToEffect>(link_effecttoeffect8, dataSource, Link_EffectToEffect.class,2.0);
link_effecttoeffect8.getDescriptionIDs().set(new DescriptionSection_Structured(link_effecttoeffect8,dataSource,"(Key) Event Relationship Weight of Evidence","<div class='biological-plausibility'><h3>Biological Plausibility</h3><p><p>Steroid hormones play a critical role in sexual development, homeostasis, stress-responses, carbohydrate metabolism, tumor growth, and reproduction. These hormones are primarily produced in specialized steroidogenic tissues and are synthesized from a common precursor, cholesterol. Mitochondria are a key control point for the regulation of steroid hormone biosynthesis. The first and rate-limiting step in steroidogenesis is the transfer of cholesterol from the outer mitochondrial membrane to the inner mitochondrial membrane, a process dependent on the action of StAR (Stocco, 2001) and the subsequent transport across the inner mitochondrial space into the steroidogenic pathway, which is executed by TSPO (Hauet et al., 2005). Testosterone production by Leydig cells is primarily under the control of luteinizing hormone (LH). Stimulation of the Leydig cells results in the activation of StAR transcription and translation, which facilitates the transfer of cholesterol into the mitochondrial matrix to cholesterol side-chain cleavage cytochrome P450 (P450scc, CYP11A), which converts cholesterol to pregnenolone. Pregnenolone diffuses to the smooth endoplasmic reticulum where it is further metabolized to testosterone via the actions of 3&beta;-hydroxysteroid dehydrogenase &Delta;5-&Delta;4-isomerase (3&beta;-HSD), 17&alpha;-hydroxylase/C17-20 lyase (P450c17, CYP17), and 17&beta;-hydroxysteroid dehydrogenase type III (17HSD3). For review see (Payne &amp; Hales, 2013). Decreased expression of genes that are responsible for cholesterol transport and steroidogenic enzyme activities in the Leydig cell leads to decreased testosterone production.</p>\n\n</p></div><div class='empirical-support-for-linkage'><h3>Empirical Support for Linkage</h3><p><p>There is evidence from experimental work that demonstrates a coordinated reduction in the expression of key genes and proteins that are involved in cholesterol transport and steroidogenesis, together with a corresponding reduction in testosterone in testes. For details see Table 1. Foetal Leydig cells exhibit a high rate of lipid metabolism, which is required for both synthesizing and importing the testosterone precursor cholesterol. Upon exposure to some chemicals mRNA expression of genes in these pathways are profoundly reduced e.g. following 500mg/kg phthalate (DBP) exposure (Johnson, McDowell, Viereck, &amp; Xia, 2011), (Thompson et al., 2005). Additionally, after phthalate exposure testis cholesterol and cholesterol-containing lipid droplets in foetal Leydig cells are also reduced (Barlow et al., 2003), (Johnson et al., 2011), (Lehmann, Phillips, Sar, Foster, &amp; Gaido, 2004).</p>\n\n<p>&nbsp;</p>\n\n<table class=\"wikitable\" id=\"Event438\">\n\n	<tbody>\n\n		<tr>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p><strong>KE: Cholesterol transport, reduction</strong></p>\n\n			</td>\n\n			<td>\n\n			<p><strong>KE: Testosterone production/levels, reduction</strong></p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Compound</p>\n\n			</td>\n\n			<td>\n\n			<p>Species</p>\n\n			</td>\n\n			<td>\n\n			<p>Effect level</p>\n\n			</td>\n\n			<td>\n\n			<p>Translator protein (TSPO), decrease; Steroidogenic acute regulatory protein (StAR) decrease</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=500 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>mRNA StAR decrease (by ~34%)(Barlow et al., 2003)</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (BBP, DPeP, DEHP, DHP, DiHeP, DCHP, DINP DHeP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP, DEHP, BBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>Rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=750 mg/kg/day (GD14-18)</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>testosterone production, reduction ex vivo fetal testes examined on GD18 (Wilson et al., 2004)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=500 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>reduced Leydig cell lipid content(Barlow et al., 2003)</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=500 mg/kg/day GD 12 -20, examinations on GD20</p>\n\n			</td>\n\n			<td>\n\n			<p>total cholesterol levels, reduction</p>\n\n			</td>\n\n			<td>\n\n			<p>intratesticular testosterone levels, reduction (by nearly 90%)(Johnson et al., 2011)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=500 mg/kg/day (GD12-19)</p>\n\n			</td>\n\n			<td>\n\n			<p>decrease uptake of cholesterol Leydig cell mitochondria gd 19</p>\n\n			</td>\n\n			<td>\n\n			<pre>\n\ntestosterone production, reduction ex vivo (Thompson, Ross, &amp; Gaido, 2004)\n\n</pre>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>mouse</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=1 g/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>reduced TSPO mRNA</p>\n\n			</td>\n\n			<td>\n\n			<p>testosterone levels, reduction (Gazouli, 2002)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=300&nbsp;mg/ kg/day</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>dose-dependently reduced StAR, TSOP mRNA (GD 21 testes), also on protein levels in Leydig cells (Borch, Metzdorff, Vinggaard, Brokken, &amp; Dalgaard, 2006)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=300&nbsp;mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>testosterone production, reduction (ex vivo) testosterone levels, reduction (Borch et al., 2006), (Borch, Ladefoged, Hass, &amp; Vinggaard, 2004)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (MEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>mouse</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=100 &mu;M</p>\n\n			</td>\n\n			<td>\n\n			<ul>\n\n				<li>\n\n				<p>reduced TSPO mRNA levels by 50%,</p>\n\n				</li>\n\n				<li>\n\n				<p>binding sites decreased by 50%</p>\n\n				</li>\n\n				<li>\n\n				<p>no effect on receptor affinity</p>\n\n				</li>\n\n				<li>\n\n				<p>inhibited the transfer or loading of cholesterol to the inner mitochondrial membrane P450scc. (Gazouli, 2002)</p>\n\n				</li>\n\n			</ul>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (MEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>IC50 =100 &mu;M</p>\n\n			</td>\n\n			<td>\n\n			<ul>\n\n				<li>\n\n				<p>inhibited formation of progesterone (Gazouli, 2002)</p>\n\n				</li>\n\n			</ul>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (MEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=250&nbsp;&mu;M</p>\n\n			</td>\n\n			<td>\n\n			<p>cholesterol transport, decrease (into the mitochondria of immature and adult Leydig cells)</p>\n\n			</td>\n\n			<td>\n\n			<p>Testosterone, reduction by approximately 60%, in vitro ( immature and adult Leydig cells) (Svechnikov, Svechnikova, &amp; S&ouml;der, 2008)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=750 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>testosterone production reduction, testosterone levels, reduction (testicular and whole-body T levels in fetal and neonatal male rats from GD 17 to PND 2. (Parks, 2000)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (MEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=1 &mu;M</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>testosterone production, reduction dose-dependent (Chauvign&eacute; et al., 2011)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Perfluorooctanoic acid (PFOA)</p>\n\n			</td>\n\n			<td>\n\n			<p>mouse</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=5mg/kg/day</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>plasma testosterone, reduction (by 37%)(Li et al., 2011)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>WY-14,643</p>\n\n			</td>\n\n			<td>\n\n			<p>mouse</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=50 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>reduced TSPO mRNA</p>\n\n			</td>\n\n			<td>\n\n			<p>Serum testosterone levels, reduction (Gazouli, 2002)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>WY-14,643</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>No decrease of testosterone ( ex vivo), (Furr, Lambright, Wilson, Foster, &amp; Gray, 2014)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>WY-14,643</p>\n\n			</td>\n\n			<td>\n\n			<p>mouse</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=100 &mu;M</p>\n\n			</td>\n\n			<td>\n\n			<p>Inhibited progesterone synthesis (Gazouli, 2002)</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Bezafibrate</p>\n\n			</td>\n\n			<td>\n\n			<p>mouse</p>\n\n			</td>\n\n			<td>\n\n			<p>IC50=100 &mu;M</p>\n\n			</td>\n\n			<td>\n\n			<ul>\n\n				<li>\n\n				<p>a dose-dependent 10&ndash;95% inhibition of the progesterone synthesis at 24 or 72 h</p>\n\n				</li>\n\n				<li>\n\n				<p>inhibited the transfer or loading of cholesterol to the inner mitochondrial membrane P450scc. At 100 &mu;M</p>\n\n				</li>\n\n				<li>\n\n				<p>binding sites of TSPO decreased IC50 of approximately 100 &mu;M</p>\n\n				</li>\n\n				<li>\n\n				<p>decrease TSPO levels by 60% at 100 &mu;M (Gazouli, 2002)</p>\n\n				</li>\n\n			</ul>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Bezafibrate</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>IC50 = 30 &mu;M</p>\n\n			</td>\n\n			<td>\n\n			<p>inhibited formation of progesterone (Gazouli, 2002)</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Bezafibrate</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>IC50 ~10&minus;4 &mu;M</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>testosterone production, reduction (Gazouli, 2002)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DiBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>GD 19 -21</p>\n\n			</td>\n\n			<td>\n\n			<p>reduced StAR, (Boberg et al., 2008)</p>\n\n			</td>\n\n			<td>\n\n			<p>testicular testosterone production and testicular testosterone levels, (Boberg et al., 2008)</p>\n\n			</td>\n\n		</tr>\n\n	</tbody>\n\n</table>\n\n<p><br />\n\nTable 1. Summary table of empirical support for this KER. IC50 half maximal inhibitory concentration, LOEC-lowest effect concentration, LOEL- lowest observed effect level, Dibutyl phthalate (DBP), diisobutyl phthalate (DiBP), Bis(2-ethylhexyl) phthalate (DEHP), Dibutyl phthalate (DBP), Bezafibrate and WY-14,643 are PPAR&alpha; ligands, n.a - not available</p>\n\n</p></div><div class='uncertainties-or-inconsistencies'><h3>Uncertainties or Inconsistencies</h3><p><p>Thompson et al investigated time course effects of phthalate on steroidogenesis gene expression and testosterone concentration. The study showed diminished concentration testosterone concentration in the foetal testis by 50% within 1h of treatment with phthalate (DBP). Surprisingly, the diminution in testosterone concentration preceded any alteration in expression of genes in the steroidogenesis pathway. Star mRNA was significantly diminished 2 h after DBP exposure, but Cyp11a1, Cyp17a1, and Scarb1 did not show a significant decrease in expression until 6 h after DBP exposure (Thompson et al., 2005). In utero exposure of rats to PFOA 20 mg/kg did not cause any effect on fetal testosterone (Boberg et.al. 2008) although in mice (adult) the decrease level of testosterone was observed. Testosterone production may also be diminished due to reduction/inhibition of other genes involved in steroidogenesis (e.g. P450scc, Cyp17a1) (Thompson et al., 2004), (Boberg et al., 2008), (Chauvign&eacute; et al., 2009), (Chauvign&eacute; et al., 2011).</p>\n\n</p></div>", link_effecttoeffect8_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);
link_effecttoeffect8.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect8,dataSource,"Evidence Supporting Taxonomic Applicability","<p>See Table 1.</p>\n\n").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 2);
link_effecttoeffect8.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect8,dataSource,"Quantitative Understanding","<p>Evidence support: Unspecified</p><p></p>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 3);

link_effecttoeffect10 = new Link_EffectToEffect(pathway, dataSource,effect_downstreameffect7, effect_downstreameffect9);
link_effecttoeffect10.setLinkType(LinkType.DIRECT);link_effecttoeffect10.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect10,dataSource,"Description","<div class='description'><h3>Description</h3><p><p>Impairment of testosterone production in testes directly impacts on testosterone levels.</p>\n\n</p></div><div class='references'><h3>References</h3><p><p>Akingbemi, B. T. 2001. &ldquo;Modulation of Rat Leydig Cell Steroidogenic Function by Di(2-Ethylhexyl)Phthalate.&rdquo; Biology of Reproduction 65 (4) (October 1): 1252&ndash;1259. doi:10.1095/biolreprod65.4.1252.</p>\n\n<p>Borch, Julie, Ole Ladefoged, Ulla Hass, and Anne Marie Vinggaard. 2004. &ldquo;Steroidogenesis in Fetal Male Rats Is Reduced by DEHP and DINP, but Endocrine Effects of DEHP Are Not Modulated by DEHA in Fetal, Prepubertal and Adult Male Rats.&rdquo; Reproductive Toxicology (Elmsford, N.Y.) 18 (1): 53&ndash;61. doi:10.1016/j.reprotox.2003.10.011.</p>\n\n<p>Borch, Julie, Stine Broeng Metzdorff, Anne Marie Vinggaard, Leon Brokken, and Majken Dalgaard. 2006. &ldquo;Mechanisms Underlying the Anti-Androgenic Effects of Diethylhexyl Phthalate in Fetal Rat Testis.&rdquo; Toxicology 223 (1-2) (June 1): 144&ndash;55. doi:10.1016/j.tox.2006.03.015.</p>\n\n<p>Culty, Martine, Raphael Thuillier, Wenping Li, Yan Wang, Daniel B Martinez-Arguelles, Carolina Gesteira Benjamin, Kostantinos M Triantafilou, Barry R Zirkin, and Vassilios Papadopoulos. 2008. &ldquo;In Utero Exposure to Di-(2-Ethylhexyl) Phthalate Exerts Both Short-Term and Long-Lasting Suppressive Effects on Testosterone Production in the Rat.&rdquo; Biology of Reproduction 78 (6) (June): 1018&ndash;28. doi:10.1095/biolreprod.107.065649.</p>\n\n<p>Hannas, Bethany R, Christy S Lambright, Johnathan Furr, Nicola Evans, Paul M D Foster, Earl L Gray, and Vickie S Wilson. 2012. &ldquo;Genomic Biomarkers of Phthalate-Induced Male Reproductive Developmental Toxicity: A Targeted RT-PCR Array Approach for Defining Relative Potency.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 125 (2) (February): 544&ndash;57. doi:10.1093/toxsci/kfr315.</p>\n\n<p>Parks, L. G. 2000. &ldquo;The Plasticizer Diethylhexyl Phthalate Induces Malformations by Decreasing Fetal Testosterone Synthesis during Sexual Differentiation in the Male Rat.&rdquo; Toxicological Sciences 58 (2) (December 1): 339&ndash;349. doi:10.1093/toxsci/58.2.339.</p>\n\n<p>Shultz, V. D. 2001. &ldquo;Altered Gene Profiles in Fetal Rat Testes after in Utero Exposure to Di(n-Butyl) Phthalate.&rdquo; Toxicological Sciences 64 (2) (December 1): 233&ndash;242. doi:10.1093/toxsci/64.2.233.</p>\n\n<p>Wilson, Vickie S., Christy Lambright, Johnathan Furr, Joseph Ostby, Carmen Wood, Gary Held, and L.Earl Gray. 2004. &ldquo;Phthalate Ester-Induced Gubernacular Lesions Are Associated with Reduced insl3 Gene Expression in the Fetal Rat Testis.&rdquo; Toxicology Letters 146 (3) (February): 207&ndash;215. doi:10.1016/j.toxlet.2003.09.012.</p>\n\n</p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Link_EffectToEffect> link_effecttoeffect10_weigth1= new ReferenceIDW<Link_EffectToEffect>(link_effecttoeffect10, dataSource, Link_EffectToEffect.class,3.0);
link_effecttoeffect10.getDescriptionIDs().set(new DescriptionSection_Structured(link_effecttoeffect10,dataSource,"(Key) Event Relationship Weight of Evidence","<div class='biological-plausibility'><h3>Biological Plausibility</h3><p><p>Within the testes, steroid synthesis takes place within the mitochondria of Leydig cells. Testosterone production by Leydig cells is primarily under the control of LH. LH indirectly stimulates the transfer of cholesterol into the mitochondrial matrix to cholesterol side-chain cleavage cytochrome P450 (P450scc, CYP11A), which converts cholesterol to pregnenolone. Pregnenolone diffuses to the smooth endoplasmic reticulum where it is further metabolized to testosterone via the actions of 3&beta;-hydroxysteroid dehydrogenase &Delta;5-&Delta;4-isomerase (3&beta;-HSD), 17&alpha;-hydroxylase/C17-20 lyase (P450c17, CYP17), and 17&beta;-hydroxysteroid dehydrogenase type III (17HSD3). For review see (Payne &amp; Hales, 2013). Therefore, inhibition or impairment of the testosterone production directly impacts on the levels of testosterone.</p>\n\n</p></div><div class='empirical-support-for-linkage'><h3>Empirical Support for Linkage</h3><p><p>There is evidence from experimental work that demonstrates a coordinated, dose-dependent reduction in the production of testosterone and consecutive reduction of testosterone levels in foetal testes and in serum, see Table 1.</p>\n\n<table class=\"wikitable\" id=\"Event439\">\n\n	<tbody>\n\n		<tr>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p><strong>KE: testosterone synthesis, reduction</strong></p>\n\n			</td>\n\n			<td>\n\n			<p><strong>KE: testosterone, reduction</strong></p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Compound</p>\n\n			</td>\n\n			<td>\n\n			<p>Species</p>\n\n			</td>\n\n			<td>\n\n			<p>Effect level</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>Details</p>\n\n			</td>\n\n			<td>\n\n			<p>References</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL =300&nbsp;mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>testicular testosterone production, reduction (ex vivo)</p>\n\n			</td>\n\n			<td>\n\n			<p>testicular testosterone levels, reduction, no change plasma testosterone</p>\n\n			</td>\n\n			<td>\n\n			<p>testosterone levels at GD 21 in male rat fetuses exposed to 0, 10, 30, 100, or 300&nbsp;mg /kg bw/day from GD 7 to GD 21 testicular testosterone production ex vivo</p>\n\n			</td>\n\n			<td>\n\n			<p>(Borch, Metzdorff, Vinggaard, Brokken, &amp; Dalgaard, 2006)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL =50 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>testicular testosterone levels, reduction,</p>\n\n			</td>\n\n			<td>\n\n			<p>Testicular testosterone was reduced &gt;50 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>(Shultz, 2001)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=300 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>fetal testicular testosterone production, reduction</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Borch, Ladefoged, Hass, &amp; Vinggaard, 2004)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=300 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>testicular testosterone levels, reduction,</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Borch et al., 2004)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=300 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>No change plasma testosterone</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Borch et al., 2004)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=100 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>Serum testosterone levels, reduction,</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Akingbemi, 2001)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=750 mg /kg /day</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>testicular testosterone levels, reduction, by 60 &ndash; 85%</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Parks, 2000)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=750 mg /kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>testosterone levels, reduction, fetuses on GD 17 (71% lower than controls) and 18 (47% lower than controls)</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Parks, 2000)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=750mg/kg/day</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>ex vivo testosterone production, reduction by 50%</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Wilson et al., 2004)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=234 mg/kg/day</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>serum testosterone levels, reduction,</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Culty et al., 2008)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=1250 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p><em>ex vivo</em> foetal testicular production</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Culty et al., 2008)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>ED50=444,2 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p><em>ex vivo</em> foetal testicular production, reduction</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p><br />\n\n			(Hannas et al., 2012)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>ED50=75.25 mg/kg/day</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p><em>ex vivo</em> foetal testicular production, reduction</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Hannas et al., 2012)</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n		</tr>\n\n	</tbody>\n\n</table>\n\n<p>Table 1. Summary table for empirical support for this KER. ED50 - half maximal effective concentration, LOEL- lowest observed effect level, Dibutyl phthalate (DBP), Bis(2-ethylhexyl) phthalate (DEHP), Dihexyl Phthalate (DHP).</p>\n\n</p></div>", link_effecttoeffect10_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);
link_effecttoeffect10.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect10,dataSource,"Evidence Supporting Taxonomic Applicability","<p>Ses Table 1.</p>\n\n").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 2);
link_effecttoeffect10.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect10,dataSource,"Quantitative Understanding","<p>Evidence support: Unspecified</p><p></p>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 3);

link_effecttoeffect11 = new Link_EffectToEffect(pathway, dataSource,effect_molecularinitiatingevent1, effect_downstreameffect4);
link_effecttoeffect11.setLinkType(LinkType.INDIRECT);link_effecttoeffect11.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect11,dataSource,"Description","<div class='description'><h3>Description</h3><p><p>The direct link of PPAR&alpha; in regulation of the cholesterol transport in mitochondria and hormone synthesis derives from studies demonstrating that PPAR&alpha; may act as indirect transrepressor of the key steroidogenic factor-1 (SF-1) (S. Plummer et al. 2007), (S. M. Plummer et al. 2013). SF-1 is a transcription factor essential for expression of genes involved in steroidogenesis (including Steroidogenic acute regulatory protein (StAR)).</p>\n\n</p></div><div class='references'><h3>References</h3><p><p>Bility, Moses T, Jerry T Thompson, Richard H McKee, Raymond M David, John H Butala, John P Vanden Heuvel, and Jeffrey M Peters. 2004. &ldquo;Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors (PPARs) by Phthalate Monoesters.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 82 (1) (November): 170&ndash;82. doi:10.1093/toxsci/kfh253. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/15310864\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/15310864</a>.</p>\n\n<p>Boberg, Julie, Stine Metzdorff, Rasmus Wortziger, Marta Axelstad, Leon Brokken, Anne Marie Vinggaard, Majken Dalgaard, and Christine Nellemann. 2008. &ldquo;Impact of Diisobutyl Phthalate and Other PPAR Agonists on Steroidogenesis and Plasma Insulin and Leptin Levels in Fetal Rats.&rdquo; Toxicology 250 (2-3) (September 4): 75&ndash;81. doi:10.1016/j.tox.2008.05.020. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/18602967\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/18602967</a>.</p>\n\n<p>Borch, Julie, Stine Broeng Metzdorff, Anne Marie Vinggaard, Leon Brokken, and Majken Dalgaard. 2006. &ldquo;Mechanisms Underlying the Anti-Androgenic Effects of Diethylhexyl Phthalate in Fetal Rat Testis.&rdquo; Toxicology 223 (1-2) (June 1): 144&ndash;55. doi:10.1016/j.tox.2006.03.015. <a class=\"external free\" href=\"http://www.sciencedirect.com/science/article/pii/S0300483X0600165X\" rel=\"nofollow\" target=\"_blank\">http://www.sciencedirect.com/science/article/pii/S0300483X0600165X</a>.</p>\n\n<p>Corton, JC, C Bocos, ES Moreno, A Merritt, DS Marsman, PJ Sausen, RC Cattley, and JA Gustafsson. 1996. &ldquo;Rat 17 Beta-Hydroxysteroid Dehydrogenase Type IV Is a Novel Peroxisome Proliferator-Inducible Gene.&rdquo; Mol. Pharmacol. 50 (5) (November 1): 1157&ndash;1166. <a class=\"external free\" href=\"http://molpharm.aspetjournals.org/content/50/5/1157.abstract?ijkey=a767a7a5a99dd83cc9fe3e4b601372c7ea4caa62&amp;keytype2=tf_ipsecsha\" rel=\"nofollow\" target=\"_blank\">http://molpharm.aspetjournals.org/content/50/5/1157.abstract?ijkey=a767a7a5a99dd83cc9fe3e4b601372c7ea4caa62&amp;keytype2=tf_ipsecsha</a>.</p>\n\n<p>Gazouli, M. 2002. &ldquo;Effect of Peroxisome Proliferators on Leydig Cell Peripheral-Type Benzodiazepine Receptor Gene Expression, Hormone-Stimulated Cholesterol Transport, and Steroidogenesis: Role of the Peroxisome Proliferator-Activator Receptor .&rdquo; Endocrinology 143 (7) (July 1): 2571&ndash;2583. doi:10.1210/en.143.7.2571. <a class=\"external free\" href=\"http://endo.endojournals.org/content/143/7/2571\" rel=\"nofollow\" target=\"_blank\">http://endo.endojournals.org/content/143/7/2571</a>.</p>\n\n<p>Hannas, Bethany R, Christy S Lambright, Johnathan Furr, Nicola Evans, Paul M D Foster, Earl L Gray, and Vickie S Wilson. 2012. &ldquo;Genomic Biomarkers of Phthalate-Induced Male Reproductive Developmental Toxicity: A Targeted RT-PCR Array Approach for Defining Relative Potency.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 125 (2) (February): 544&ndash;57. doi:10.1093/toxsci/kfr315. <a class=\"external free\" href=\"http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3262859&amp;tool=pmcentrez&amp;rendertype=abstract\" rel=\"nofollow\" target=\"_blank\">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3262859&amp;tool=pmcentrez&amp;rendertype=abstract</a>.</p>\n\n<p>Hermanowski-Vosatka, A, D Gerhold, S S Mundt, V A Loving, M Lu, Y Chen, A Elbrecht, et al. 2000. &ldquo;PPARalpha Agonists Reduce 11beta-Hydroxysteroid Dehydrogenase Type 1 in the Liver.&rdquo; Biochemical and Biophysical Research Communications 279 (2) (December 20): 330&ndash;6. doi:10.1006/bbrc.2000.3966. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/11118287\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/11118287</a>.</p>\n\n<p>Hurst, Christopher H, and David J Waxman. 2003. &ldquo;Activation of PPARalpha and PPARgamma by Environmental Phthalate Monoesters.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 74 (2) (August): 297&ndash;308. doi:10.1093/toxsci/kfg145. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/12805656\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/12805656</a>.</p>\n\n<p>Lapinskas, Paula J., Sherri Brown, Lisa M. Leesnitzer, Steven Blanchard, Cyndi Swanson, Russell C. Cattley, and J. Christopher Corton. 2005. &ldquo;Role of PPAR&alpha; in Mediating the Effects of Phthalates and Metabolites in the Liver.&rdquo; Toxicology 207 (1): 149&ndash;163. <a class=\"external free\" href=\"http://www.sciencedirect.com/science/article/pii/S0300483X04005633\" rel=\"nofollow\" target=\"_blank\">http://www.sciencedirect.com/science/article/pii/S0300483X04005633</a>.</p>\n\n<p>Lehmann, Kim P, Suzanne Phillips, Madhabananda Sar, Paul M D Foster, and Kevin W Gaido. 2004. &ldquo;Dose-Dependent Alterations in Gene Expression and Testosterone Synthesis in the Fetal Testes of Male Rats Exposed to Di (n-Butyl) Phthalate.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 81 (1) (September 1): 60&ndash;8. doi:10.1093/toxsci/kfh169. <a class=\"external free\" href=\"http://toxsci.oxfordjournals.org/content/81/1/60.abstract?ijkey=99364980d6548f969a82406deb6600873a38be36&amp;keytype2=tf_ipsecsha\" rel=\"nofollow\" target=\"_blank\">http://toxsci.oxfordjournals.org/content/81/1/60.abstract?ijkey=99364980d6548f969a82406deb6600873a38be36&amp;keytype2=tf_ipsecsha</a>.</p>\n\n<p>Li, Yufei, Doni Hikmat Ramdhan, Hisao Naito, Nozomi Yamagishi, Yuki Ito, Yumi Hayashi, Yukie Yanagiba, et al. 2011. &ldquo;Ammonium Perfluorooctanoate May Cause Testosterone Reduction by Adversely Affecting Testis in Relation to PPAR&alpha;.&rdquo; Toxicology Letters 205 (3) (September 10): 265&ndash;72. doi:10.1016/j.toxlet.2011.06.015. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/21712084\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/21712084</a>.</p>\n\n<p>Liu, Kejun, Kim P Lehmann, Madhabananda Sar, S Stanley Young, and Kevin W Gaido. 2005. &ldquo;Gene Expression Profiling Following in Utero Exposure to Phthalate Esters Reveals New Gene Targets in the Etiology of Testicular Dysgenesis.&rdquo; Biology of Reproduction 73 (1) (July): 180&ndash;92. doi:10.1095/biolreprod.104.039404. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/15728792\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/15728792</a>.</p>\n\n<p>McCampbell, A. 2000. &ldquo;CREB-Binding Protein Sequestration by Expanded Polyglutamine.&rdquo; Human Molecular Genetics 9 (14) (September 1): 2197&ndash;2202. doi:10.1093/hmg/9.14.2197. <a class=\"external free\" href=\"http://hmg.oxfordjournals.org/content/9/14/2197.abstract?ijkey=c35580e57df64d1fc98fb242bf4ed19362a4a3ce&amp;keytype2=tf_ipsecsha\" rel=\"nofollow\" target=\"_blank\">http://hmg.oxfordjournals.org/content/9/14/2197.abstract?ijkey=c35580e57df64d1fc98fb242bf4ed19362a4a3ce&amp;keytype2=tf_ipsecsha</a>.</p>\n\n<p>Plummer, Simon M, Dhritiman Dan, Joanne Quinney, Nina Hallmark, Richard D Phillips, Michael Millar, Sheila Macpherson, and Clifford R Elcombe. 2013. &ldquo;Identification of Transcription Factors and Coactivators Affected by Dibutylphthalate Interactions in Fetal Rat Testes.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 132 (2) (April): 443&ndash;57. doi:10.1093/toxsci/kft016. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/23358192\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/23358192</a>.</p>\n\n<p>Plummer, Simon, Richard M Sharpe, Nina Hallmark, Isobel Kim Mahood, and Cliff Elcombe. 2007. &ldquo;Time-Dependent and Compartment-Specific Effects of in Utero Exposure to Di(n-Butyl) Phthalate on Gene/protein Expression in the Fetal Rat Testis as Revealed by Transcription Profiling and Laser Capture Microdissection.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 97 (2) (June 1): 520&ndash;32. doi:10.1093/toxsci/kfm062. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/17379624\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/17379624</a>.</p>\n\n<p>Schultz, R, W Yan, J Toppari, A V&ouml;lkl, J A Gustafsson, and M Pelto-Huikko. 1999. &ldquo;Expression of Peroxisome Proliferator-Activated Receptor Alpha Messenger Ribonucleic Acid and Protein in Human and Rat Testis.&rdquo; Endocrinology 140 (7) (July): 2968&ndash;75. doi:10.1210/endo.140.7.6858. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/10385388\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/10385388</a>.</p>\n\n<p>Shultz, V. D. 2001. &ldquo;Altered Gene Profiles in Fetal Rat Testes after in Utero Exposure to Di(n-Butyl) Phthalate.&rdquo; Toxicological Sciences 64 (2) (December 1): 233&ndash;242. doi:10.1093/toxsci/64.2.233. <a class=\"external free\" href=\"http://toxsci.oxfordjournals.org/content/64/2/233.abstract?ijkey=b8af27acfe10695847a4e8a9b568882405d071ae&amp;keytype2=tf_ipsecsha\" rel=\"nofollow\" target=\"_blank\">http://toxsci.oxfordjournals.org/content/64/2/233.abstract?ijkey=b8af27acfe10695847a4e8a9b568882405d071ae&amp;keytype2=tf_ipsecsha</a>. Stocco, D M. 2001. &ldquo;StAR Protein and the Regulation of Steroid Hormone Biosynthesis.&rdquo; Annual Review of Physiology 63 (January): 193&ndash;213. doi:10.1146/annurev.physiol.63.1.193. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/11181954\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/11181954</a>.</p>\n\n<p>Sugawara, T, J A Holt, M Kiriakidou, and J F Strauss. 1996. &ldquo;Steroidogenic Factor 1-Dependent Promoter Activity of the Human Steroidogenic Acute Regulatory Protein (StAR) Gene.&rdquo; Biochemistry 35 (28) (July 16): 9052&ndash;9. doi:10.1021/bi960057r. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/8703908\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/8703908</a>.</p>\n\n<p>Toda, Katsumi, Teruhiko Okada, Chisata Miyaura, and Toshiji Saibara. 2003. &ldquo;Fenofibrate, a Ligand for PPARalpha, Inhibits Aromatase Cytochrome P450 Expression in the Ovary of Mouse.&rdquo; Journal of Lipid Research 44 (2) (February): 265&ndash;70. doi:10.1194/jlr.M200327-JLR200. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/12576508\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/12576508</a>. ToxCastTM Data. &ldquo;ToxCastTM Data.&rdquo; US Environmental Protection Agency. <a class=\"external free\" href=\"http://www.epa.gov/ncct/toxcast/data.html\" rel=\"nofollow\" target=\"_blank\">http://www.epa.gov/ncct/toxcast/data.html</a>.</p>\n\n<p>Vanden Heuvel, John P, Jerry T Thompson, Steven R Frame, and Peter J Gillies. 2006. &ldquo;Differential Activation of Nuclear Receptors by Perfluorinated Fatty Acid Analogs and Natural Fatty Acids: A Comparison of Human, Mouse, and Rat Peroxisome Proliferator-Activated Receptor-Alpha, -Beta, and -Gamma, Liver X Receptor-Beta, and Retinoid X Rec.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 92 (2) (August): 476&ndash;89. doi:10.1093/toxsci/kfl014. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/16731579\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/16731579</a>.</p>\n\n<p>Walsh, L P, C N Kuratko, and D M Stocco. 2000. &ldquo;Econazole and Miconazole Inhibit Steroidogenesis and Disrupt Steroidogenic Acute Regulatory (StAR) Protein Expression Post-Transcriptionally.&rdquo; The Journal of Steroid Biochemistry and Molecular Biology 75 (4-5) (December 31): 229&ndash;36. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/11282276\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/11282276</a>.</p>\n\n<p>Wong, Jean S, Xiaoqin Ye, Christy R Muhlenkamp, and Sarjeet S Gill. 2002. &ldquo;Effect of a Peroxisome Proliferator on 3 Beta-Hydroxysteroid Dehydrogenase.&rdquo; Biochemical and Biophysical Research Communications 293 (1) (April 26): 549&ndash;53. doi:10.1016/S0006-291X(02)00235-8. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/12054636\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/12054636</a>.</p>\n\n</p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Link_EffectToEffect> link_effecttoeffect11_weigth1= new ReferenceIDW<Link_EffectToEffect>(link_effecttoeffect11, dataSource, Link_EffectToEffect.class,2.0);
link_effecttoeffect11.getDescriptionIDs().set(new DescriptionSection_Structured(link_effecttoeffect11,dataSource,"(Key) Event Relationship Weight of Evidence","<div class='biological-plausibility'><h3>Biological Plausibility</h3><p><p>The PPAR&alpha; is expressed in foetal rat Leydig cells (Boberg et al. 2008), (S. M. Plummer et al. 2013) and in adult rat Leydig cells (Schultz et al. 1999). Recent studies have shown that foetal testes contained PPAR&alpha; protein&ndash;binding peaks in CYP11a, StAR, and CYP17a regulatory regions (S. M. Plummer et al. 2013). Binding of PPAR&alpha; to promoter of steroidogenic gene occurs at binding sites different from those of SF-1, indicating that PPAR&alpha; may be an indirect repressor of SF1 binding. Moreover, it is possible that PPAR&alpha; could act via sequestration of the shared coactivator CBP (S. M. Plummer et al. 2013). PPAR&alpha; and SF-1 share a common coactivator, CREB-binding protein (CBP), which is present in limited concentrations (McCampbell 2000). Binding of CBP to PPAR&alpha; could therefore starve SF-1 from a cofactor essential for its transactivation functions. SF-1 controls transcription of the StAR gene (Sugawara et al. 1996). Steroidogenic acute regulatory (StAR) protein plays a critical role in the movement of cholesterol from the outer to the inner mitochondrial membrane (Stocco 2001). Hence, it seems likely that the ability of PPAR&alpha; to interfere with SF-1 binding/transactivation caused by exposure to chemicals (e.g. phthalates) could affect the StAR expression and the cholesterol transport in mitochondria.</p>\n\n</p></div><div class='empirical-support-for-linkage'><h3>Empirical Support for Linkage</h3><p><p>PPAR&alpha; agonists can suppress Leydig cell steroidogenesis (Gazouli 2002), and downregulate steroidogenic genes including StAR (Borch et al. 2006), (Lehmann et al. 2004), (Liu et al. 2005), for details see Table 1. Moreover, PPAR&alpha; agonists, which do not directly transrepress the StAR promoter, have been found to downregulate the expression of this gene in steroidogenic tissues (in mice ovaries) (Toda et al. 2003).</p>\n\n<p>&nbsp;</p>\n\n<table class=\"wikitable\" id=\"KER369\">\n\n	<tbody>\n\n		<tr>\n\n			<td>\n\n			<p>Compound</p>\n\n			</td>\n\n			<td>\n\n			<p>species</p>\n\n			</td>\n\n			<td>\n\n			<p>KE: PPAR&alpha;, Activation</p>\n\n			</td>\n\n			<td>\n\n			<p>KE: StAR, Decrease</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (MBzP )</p>\n\n			</td>\n\n			<td>\n\n			<p>human</p>\n\n			</td>\n\n			<td>\n\n			<p>EC50 = 30 &mu;M human (Hurst and Waxman 2003)</p>\n\n			</td>\n\n			<td>\n\n			<p>n.a.</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rodent</p>\n\n			</td>\n\n			<td>\n\n			<p>EC50 = 21 &mu;M MBzP</p>\n\n			<p>EC50 = 63 &mu;M (Hurst and Waxman 2003) MBuP</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=50 mg/kg/day (Borch et al. 2006) (Lehmann et al. 2004), (Shultz 2001)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (MEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rodent</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=30 &mu;M (Bility et al. 2004)</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=300 mg/kg/day (Borch et al. 2006)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (MEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>human</p>\n\n			</td>\n\n			<td>\n\n			<p>Ki=15 &micro;M (Lapinskas et al. 2005)</p>\n\n			<p>EC50 = 3.2 &mu;M</p>\n\n			<p>(Hurst and Waxman 2003)</p>\n\n			</td>\n\n			<td>\n\n			<p>n.a.</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DiBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=600 mg/kg/day, decrease of PPAR&alpha; mRNA, at GD 19 and 21 in testes of foetuses (Boberg et al. 2008)</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=600 mg/kg/day, decrease of StAR mRNA at GD 19 and 21 in testes of foetuses (Boberg et al. 2008)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Econazole</p>\n\n			</td>\n\n			<td>\n\n			<p>rodent</p>\n\n			</td>\n\n			<td>\n\n			<p>AC50=0.0729 &mu;M (ToxCastTM Data)</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=25 &mu;M, mouse MA-10 Leydig tumor cell line, Decrease in StAR activity and/or expression (Walsh, Kuratko, and Stocco 2000)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Perfluorooctanoate (PFOA)</p>\n\n			</td>\n\n			<td>\n\n			<p>mice</p>\n\n			</td>\n\n			<td>\n\n			<p>3T3-L1 cells transfected with human, mouse and rat PPAR&alpha; (Vanden Heuvel et al. 2006)</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC= 5.0 mg/kg/day mRNA StAR decrease in the testis of wild-type<em> </em>mice, LOEC=1.0 mg/kg/day mRNA StAR decrease in testis of</p>\n\n			<p><em>PPAR&alpha;-humanized</em> mice (not in the PPAR<em>&alpha;</em> &ndash;null mice) (Li et al. 2011)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Fenofibrate</p>\n\n			</td>\n\n			<td>\n\n			<p>mice</p>\n\n			</td>\n\n			<td>\n\n			<p>PPAR agonist</p>\n\n			<p>Increase PPAR&alpha; protein (Toda et al. 2003).</p>\n\n			</td>\n\n			<td>\n\n			<p>Decrease of StAR (protein level, in mice ovaries) (Toda et al. 2003)</p>\n\n			</td>\n\n		</tr>\n\n	</tbody>\n\n</table>\n\n<p>Table 1. Summary table for empirical support of KER. ED50 - half maximal effective concentration, LOEC-lowest observed effect concentration, Bis(2-ethylhexyl) phthalate (DEHP), Dibutyl phthalate (DBP), diisobutyl phthalate (DiBP), mono-sec-butyl phthalate (MBuP), n.a - not available.</p>\n\n</p></div><div class='uncertainties-or-inconsistencies'><h3>Uncertainties or Inconsistencies</h3><p><p><strong>Uncertainties</strong></p>\n\n<p>PPAR&alpha; was also shown to regulate Translator protein (TSPO), which is a mitochondrial outer membrane protein implicated in cholesterol import to the inner mitochondrial (for details see <a href=\"/wiki/index.php/Relationship:370\" title=\"Relationship:370\">Relationship:370</a>). Moreover, there is evidence that activated PPAR&alpha; regulates the expression of enzymes involved in steroid metabolism (17&beta;-hydroxysteroid dehydrogenase IV, 11&beta;-hydroxysteroid dehydrogenase I, and 3&beta;-hydroxysteroid dehydrogenase V (Hermanowski-Vosatka et al. 2000), (Corton et al. 1996), (Wong et al. 2002)).</p>\n\n<p><strong>Inconsistencies</strong> In utero rat exposure to the PPAR&alpha; agonist Wy-14,643 did not reduce fetal testis steroidogenic gene expression or testosterone production (Hannas et al. 2012).</p>\n\n</p></div>", link_effecttoeffect11_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);
link_effecttoeffect11.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect11,dataSource,"Evidence Supporting Taxonomic Applicability","<p>See Table 1.</p>\n\n").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 2);
link_effecttoeffect11.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect11,dataSource,"Quantitative Understanding","<p>Evidence support: Unspecified</p><p></p>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 3);

link_effecttoeffect13 = new Link_EffectToEffect(pathway, dataSource,effect_molecularinitiatingevent1, effect_downstreameffect12);
link_effecttoeffect13.setLinkType(LinkType.INDIRECT);link_effecttoeffect13.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect13,dataSource,"Description","<div class='description'><h3>Description</h3><p><p>Activation of PPAR&alpha; leads to decreased expression of cholesterol transport (TSPO) gene in steroidogenic cells (e.g. Leydig cell) and as a consequence the amount of cholesterol transported into mitochondria decreases (impact on steroid production).</p>\n\n</p></div><div class='references'><h3>References</h3><p><p>Bility, Moses T, Jerry T Thompson, Richard H McKee, Raymond M David, John H Butala, John P Vanden Heuvel, and Jeffrey M Peters. 2004. &ldquo;Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors (PPARs) by Phthalate Monoesters.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 82 (1) (November): 170&ndash;82. doi:10.1093/toxsci/kfh253.</p>\n\n<p>Boberg, Julie, Stine Metzdorff, Rasmus Wortziger, Marta Axelstad, Leon Brokken, Anne Marie Vinggaard, Majken Dalgaard, and Christine Nellemann. 2008. &ldquo;Impact of Diisobutyl Phthalate and Other PPAR Agonists on Steroidogenesis and Plasma Insulin and Leptin Levels in Fetal Rats.&rdquo; Toxicology 250 (2-3) (September 4): 75&ndash;81. doi:10.1016/j.tox.2008.05.020.</p>\n\n<p>Borch, Julie, Stine Broeng Metzdorff, Anne Marie Vinggaard, Leon Brokken, and Majken Dalgaard. 2006. &ldquo;Mechanisms Underlying the Anti-Androgenic Effects of Diethylhexyl Phthalate in Fetal Rat Testis.&rdquo; Toxicology 223 (1-2) (June 1): 144&ndash;55. doi:10.1016/j.tox.2006.03.015.</p>\n\n<p>Campioli, Enrico, Amani Batarseh, Jiehan Li, and Vassilios Papadopoulos. 2011. &ldquo;The Endocrine Disruptor Mono-(2-Ethylhexyl) Phthalate Affects the Differentiation of Human Liposarcoma Cells (SW 872).&rdquo; Edited by Vasu D. Appanna. PloS One 6 (12) (January 21): e28750. doi:10.1371/journal.pone.0028750.</p>\n\n<p>Gazouli, M. 2002. &ldquo;Effect of Peroxisome Proliferators on Leydig Cell Peripheral-Type Benzodiazepine Receptor Gene Expression, Hormone-Stimulated Cholesterol Transport, and Steroidogenesis: Role of the Peroxisome Proliferator-Activator Receptor .&rdquo; Endocrinology 143 (7) (July 1): 2571&ndash;2583. doi:10.1210/en.143.7.2571.</p>\n\n<p>Hannas, Bethany R, Christy S Lambright, Johnathan Furr, Nicola Evans, Paul M D Foster, Earl L Gray, and Vickie S Wilson. 2012. &ldquo;Genomic Biomarkers of Phthalate-Induced Male Reproductive Developmental Toxicity: A Targeted RT-PCR Array Approach for Defining Relative Potency.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 125 (2) (February): 544&ndash;57. doi:10.1093/toxsci/kfr315.</p>\n\n<p>Hurst, Christopher H, and David J Waxman. 2003. &ldquo;Activation of PPARalpha and PPARgamma by Environmental Phthalate Monoesters.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 74 (2) (August): 297&ndash;308. doi:10.1093/toxsci/kfg145.</p>\n\n<p>Lapinskas, Paula J., Sherri Brown, Lisa M. Leesnitzer, Steven Blanchard, Cyndi Swanson, Russell C. Cattley, and J. Christopher Corton. 2005. &ldquo;Role of PPAR&alpha; in Mediating the Effects of Phthalates and Metabolites in the Liver.&rdquo; Toxicology 207 (1): 149&ndash;163.</p>\n\n<p>Lehmann, Kim P, Suzanne Phillips, Madhabananda Sar, Paul M D Foster, and Kevin W Gaido. 2004. &ldquo;Dose-Dependent Alterations in Gene Expression and Testosterone Synthesis in the Fetal Testes of Male Rats Exposed to Di (n-Butyl) Phthalate.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 81 (1) (September 1): 60&ndash;8. doi:10.1093/toxsci/kfh169.</p>\n\n<p>Pinelli, Alessandra, Cristina Godio, Antonio Laghezza, Nico Mitro, Giuseppe Fracchiolla, Vincenzo Tortorella, Antonio Lavecchia, et al. 2005. &ldquo;Synthesis, Biological Evaluation, and Molecular Modeling Investigation of New Chiral Fibrates with PPARalpha and PPARgamma Agonist Activity.&rdquo; Journal of Medicinal Chemistry 48 (17) (August 25): 5509&ndash;19. doi:10.1021/jm0502844.</p>\n\n<p>Schultz, R, W Yan, J Toppari, A V&ouml;lkl, J A Gustafsson, and M Pelto-Huikko. 1999. &ldquo;Expression of Peroxisome Proliferator-Activated Receptor Alpha Messenger Ribonucleic Acid and Protein in Human and Rat Testis.&rdquo; Endocrinology 140 (7) (July): 2968&ndash;75. doi:10.1210/endo.140.7.6858.</p>\n\n<p>Ward, J M, J M Peters, C M Perella, and F J Gonzalez. 1998. &ldquo;Receptor and Nonreceptor-Mediated Organ-Specific Toxicity of di(2-Ethylhexyl)phthalate (DEHP) in Peroxisome Proliferator-Activated Receptor Alpha-Null Mice.&rdquo; Toxicologic Pathology 26 (2): 240&ndash;6.</p>\n\n<p>Willson, T M, P J Brown, D D Sternbach, and B R Henke. 2000. &ldquo;The PPARs: From Orphan Receptors to Drug Discovery.&rdquo; Journal of Medicinal Chemistry 43 (4) (February 24): 527&ndash;50.</p>\n\n<p>Xie, Yi, Qian Yang, and Joseph W DePierre. 2002. &ldquo;The Effects of Peroxisome Proliferators on Global Lipid Homeostasis and the Possible Significance of These Effects to Other Responses to These Xenobiotics: An Hypothesis.&rdquo; Annals of the New York Academy of Sciences 973 (November): 17&ndash;25.</p>\n\n</p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Link_EffectToEffect> link_effecttoeffect13_weigth1= new ReferenceIDW<Link_EffectToEffect>(link_effecttoeffect13, dataSource, Link_EffectToEffect.class,1.0);
link_effecttoeffect13.getDescriptionIDs().set(new DescriptionSection_Structured(link_effecttoeffect13,dataSource,"(Key) Event Relationship Weight of Evidence","<div class='biological-plausibility'><h3>Biological Plausibility</h3><p><p>PPARs are nuclear receptors that among many other functions regulate genes involved in cholesterol uptake and transport (Xie, Yang, and DePierre 2002), (Gazouli 2002), (Campioli et al. 2011). The indirect link of PPAR receptors in regulation of the cholesterol transport in mitochondria derives from studies demonstrating PPAR&alpha; dependent control of TSOP (Gazouli 2002), (Campioli et al. 2011). PPAR&alpha; is present in steroidogenic cells e.g. of the testes during its development as well as in adult testes (Schultz et al. 1999), (Boberg et al. 2008) and modulation of its activity has been shown to impact on TSOP transcriptional activity (Gazouli 2002). The exact mechanisms of this relationship are not known.</p>\n\n</p></div><div class='empirical-support-for-linkage'><h3>Empirical Support for Linkage</h3><p><p>Gazouli et al showed that PPAR activators (Bezafibrate , MEHP ) inhibited the transfer or loading of cholesterol to the inner mitochondrial membrane in MA-10 mouse Leydig tumor cells and decreased levels of TSOP protein. Additionally, in R2C (Leydig tumor cell line) inhibited the formation of progesterone. The levels of the TSPO protein were decreased in testes of adult mice exposed to and DEHP (Gazouli 2002). Moreover, the finding that benzafibrate and phthalates inhibit the hormone-induced and constitutively sustained steroidogenesis with similar IC50 values indicates that these compounds act on a common regulatory component of the steroidogenic pathway (Gazouli 2002). In in vivo studies with rats exposed to DEHP the levels of TSOP (mRNA) were decreased dose-dependently in foetal testes (GD 21 testes), also on protein levels in Leydig cells (Borch et al. 2006). For details see Table1.</p>\n\n<table border=\"1\" style=\"border-collapse:collapse; font-size:75%\">\n\n	<tbody>\n\n		<tr>\n\n			<td>\n\n			<p>Compound</p>\n\n			</td>\n\n			<td>\n\n			<p>KE: PPAR&alpha;,</p>\n\n			<p>Activation</p>\n\n			</td>\n\n			<td>\n\n			<p>KE: TSPO,</p>\n\n			<p>Decrease</p>\n\n			</td>\n\n			<td>\n\n			<p>species</p>\n\n			</td>\n\n			<td>\n\n			<p>Details</p>\n\n			</td>\n\n			<td>\n\n			<p>References</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>EC50=30&mu;M</p>\n\n			</td>\n\n			<td>\n\n			<p>n.a.</p>\n\n			</td>\n\n			<td>\n\n			<p>human</p>\n\n			</td>\n\n			<td>\n\n			<p>Monobenzyl phthalate (MBzP) metabolite of DBP</p>\n\n			</td>\n\n			<td>\n\n			<p>(Hurst and Waxman 2003)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>EC50=21&mu;M *</p>\n\n			<p>EC50=63&mu;M**</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=100 &mu;M</p>\n\n			</td>\n\n			<td>\n\n			<p>rodent</p>\n\n			</td>\n\n			<td>\n\n			<p>*MBzP</p>\n\n			<p>**mono-<em>sec</em>-butyl phthalate (MBuP) metabolite of DBP</p>\n\n			</td>\n\n			<td>\n\n			<p>(Hurst and Waxman 2003),(Gazouli 2002)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=30&mu;M</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=300&nbsp;mg/kg /d</p>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>rodent</p>\n\n			</td>\n\n			<td>\n\n			<p>MEHP metabolite of DEHP</p>\n\n			</td>\n\n			<td>\n\n			<p>(Bility et al. 2004), (Gazouli 2002), (Borch et al. 2006)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>Ki=15&micro;M;</p>\n\n			<p>EC50 = 3.2&mu;M</p>\n\n			</td>\n\n			<td>\n\n			<p>n.a.</p>\n\n			</td>\n\n			<td>\n\n			<p>human</p>\n\n			</td>\n\n			<td>\n\n			<p>MEHP metabolite of DEHP</p>\n\n			</td>\n\n			<td>\n\n			<p>(Lapinskas et al. 2005), (Hurst and Waxman 2003)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Bezafibrate</p>\n\n			</td>\n\n			<td>\n\n			<p>EC50=55&mu;M</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=100 &mu;M</p>\n\n			</td>\n\n			<td>\n\n			<p>rodent</p>\n\n			</td>\n\n			<td>\n\n			<p>TSPO decreased by 80% in MA-10 Leydig cells</p>\n\n			</td>\n\n			<td>\n\n			<p>(Willson et al. 2000), (Gazouli 2002)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>WY-14,643</p>\n\n			</td>\n\n			<td>\n\n			<p>EC50=0.00027&mu;M</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEC=50 mg/kg/d</p>\n\n			</td>\n\n			<td>\n\n			<p>rodent</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>\n\n			<p>(Pinelli et al. 2005), (Gazouli 2002)</p>\n\n			</td>\n\n		</tr>\n\n	</tbody>\n\n</table>\n\n<p>Table 1. Summary table of empirical support for this KER. ED50 - half maximal effective dose, LOEC-lowest observed effect concentration, Bis(2-ethylhexyl) phthalate (DEHP), Dibutyl phthalate (DBP), WY-14,643 and Bezafibrate ligands of PPAR&alpha;, n.a.- not available</p>\n\n</p></div><div class='uncertainties-or-inconsistencies'><h3>Uncertainties or Inconsistencies</h3><p><p>The exact mechanisms of this relationship are not known.</p>\n\n<p>&nbsp;</p>\n\n<p>Treatment of adult mice with PPAR&alpha; activator (DEHP or WY-14,643) resulted in reduced levls of circulating testosterone and testis TSPO mRNA, consistent with the in vitro effects (Gazouli 2002). In contrast, liver TSPO mRNA levels have been increased, indicating a tissue-specific regulation of TSOP expression by PPAR&alpha; activator (Gazouli 2002). In the PPAR&alpha;-null mice, compared with the wild-type controls, circulating testosterone levels were decreased suggesting a positive constitutive role for PPAR&alpha; in maintaining Leydig cell steroid formation. Surprisingly, treatment of the PPAR&alpha;-null mice with PPAR&alpha; activators (DEHP and WY-14,643) restored testosterone formation and TSPO mRNA returned to normal levels, suggesting PPAR&alpha;-independent pathways might be involved in the regulation of TSPO genes and steroidogenesis (Gazouli 2002). In support of this hypothesis, an other study demonstrated that part of the toxic effect of phthalate (DEHP) on testis was retained in PPAR&alpha;-null mice (Ward et al. 1998).</p>\n\n<p>There is some evidence involving additional PPARs in transcriptional regulation of TSPO:</p>\n\n<ul>\n\n	<li>PPAR&beta;/&delta; (Campioli et al. 2011);</li>\n\n	<li>PPAR&gamma; isoform was also detected in testes (Boberg et al. 2008) and it was reduced by treatment of DEHP in parallel with the reduction of TSPO regulation (Borch et al. 2006).</li>\n\n</ul>\n\n<p>&nbsp;</p>\n\n<p>A genomic study does not support the hypothesis that activation of PPAR&alpha;/&gamma; pathways is involved in the effects of phthalates on sexual differentiation of the male rat, as Wy-14,643 (PPAR&alpha; activator) has no effect on testosterone production and the PPAR&gamma; isoform has not been detected in testes at gestation day 14-18 (Hannas et al. 2012). Differential patterns of TSPO expression in the foetal rat testis have been observed upon phthalate (DBP) treatment, whereas TSPO mRNA up-regulated protein levels were decreased in Leydig cells (Lehmann et al. 2004).</p>\n\n</p></div>", link_effecttoeffect13_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);
link_effecttoeffect13.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect13,dataSource,"Evidence Supporting Taxonomic Applicability","<p>See Table 1.</p>\n\n").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 2);
link_effecttoeffect13.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect13,dataSource,"Quantitative Understanding","<p>Evidence support: Unspecified</p><p></p>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 3);

link_effecttoeffect15 = new Link_EffectToEffect(pathway, dataSource,effect_downstreameffect14, effect_adverseoutcome2);
link_effecttoeffect15.setLinkType(LinkType.DIRECT);link_effecttoeffect15.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect15,dataSource,"Description","<div class='description'><h3>Description</h3><p><p>Impairment in the normal development of the male reproductive tract (e.g. genital abnormality and/or cryptorchidism) can impact on fertility later in life.</p>\n\n</p></div><div class='references'><h3>References</h3><p><p>Asklund, C, T K Jensen, K M Main, T Sobotka, N E Skakkebaek, and N J&oslash;rgensen. 2010. &ldquo;Semen Quality, Reproductive Hormones and Fertility of Men Operated for Hypospadias.&rdquo; International Journal of Andrology 33 (1) (February): 80&ndash;7. doi:10.1111/j.1365-2605.2009.00957.x.</p>\n\n<p>Bracka, A. 1989. &ldquo;A Long-Term View of Hypospadias.&rdquo; British Journal of Plastic Surgery 42 (3) (May): 251&ndash;5.</p>\n\n<p>Cowin, Prue A, Elspeth Gold, Jasna Aleksova, Moira K O&rsquo;Bryan, Paul M D Foster, Hamish S Scott, and Gail P Risbridger. 2010. &ldquo;Vinclozolin Exposure in Utero Induces Postpubertal Prostatitis and Reduces Sperm Production via a Reversible Hormone-Regulated Mechanism.&rdquo; Endocrinology 151 (2) (February): 783&ndash;92. doi:10.1210/en.2009-0982.</p>\n\n<p>Eisenberg, Michael L, Michael H Hsieh, Rustin Chanc Walters, Ross Krasnow, and Larry I Lipshultz. 2011. &ldquo;The Relationship between Anogenital Distance, Fatherhood, and Fertility in Adult Men.&rdquo; PloS One 6 (5) (January): e18973. doi:10.1371/journal.pone.0018973.</p>\n\n<p>Macleod, D J, R M Sharpe, M Welsh, M Fisken, H M Scott, G R Hutchison, A J Drake, and S van den Driesche. 2010. &ldquo;Androgen Action in the Masculinization Programming Window and Development of Male Reproductive Organs.&rdquo; International Journal of Andrology 33 (2) (April): 279&ndash;87. doi:10.1111/j.1365-2605.2009.01005.x.</p>\n\n<p>Mendiola, Jaime, Richard W Stahlhut, Niels J&oslash;rgensen, Fan Liu, and Shanna H Swan. 2011. &ldquo;Shorter Anogenital Distance Predicts Poorer Semen Quality in Young Men in Rochester, New York.&rdquo; Environmental Health Perspectives 119 (7) (July): 958&ndash;63. doi:10.1289/ehp.1103421.</p>\n\n<p>NTP. 2005. &ldquo;Multigenerational Reproductive Assessment by Continuous Breeding When Diethylhexylphthalate (CAS 117-81-7).&rdquo;</p>\n\n<p>Skakkebaek, N E, E Rajpert-De Meyts, and K M Main. 2001. &ldquo;Testicular Dysgenesis Syndrome: An Increasingly Common Developmental Disorder with Environmental Aspects.&rdquo; Human Reproduction (Oxford, England) 16 (5) (May): 972&ndash;8.</p>\n\n<p>Thorup, Jorgen, Robert McLachlan, Dina Cortes, Tamara R. Nation, Adam Balic, Bridget R. Southwell, and John M. Hutson. 2010. &ldquo;What Is New in Cryptorchidism and Hypospadias - A Critical Review on the Testicular Dysgenesis Hypothesis.&rdquo; Journal of Pediatric Surgery. doi:10.1016/j.jpedsurg.2010.07.030.</p>\n\n</p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Link_EffectToEffect> link_effecttoeffect15_weigth1= new ReferenceIDW<Link_EffectToEffect>(link_effecttoeffect15, dataSource, Link_EffectToEffect.class,3.0);
link_effecttoeffect15.getDescriptionIDs().set(new DescriptionSection_Structured(link_effecttoeffect15,dataSource,"(Key) Event Relationship Weight of Evidence","<div class='biological-plausibility'><h3>Biological Plausibility</h3><p><p>Hypospadias next to cryptorchidism belongs to the most common male reproductive disorders that manifest at birth and may have a common origin in foetal life (Skakkebaek, Rajpert-De Meyts, and Main 2001) and are associated with decreased fertility (Thorup et al. 2010).</p>\n\n</p></div><div class='empirical-support-for-linkage'><h3>Empirical Support for Linkage</h3><p><p><strong>Human</strong></p>\n\n<p>Asklund et al that semen quality was reduced in men with hypospadias and additional genital disorders, predominately cryptorchidism (Asklund et al. 2010). In another study by Bracka, 25% of 41 hypospadias patients including 26 patients also with cryptorchidism had a lower sperm density (Bracka 1989). Men with a history of cryptorchidism have an increased risk of infertility (Thorup et al. 2010). Eisenberg et al. found shorter AGD among infertile men as compared with fertile men (Eisenberg et al. 2011).</p>\n\n<p><strong>Rat</strong></p>\n\n<p>In rodents in utero exposure to agents known to disrupt androgen mediated pathways corrupts normal male genital development with a decrease in genital length (ie phallus length, AGD) and impaired testosterone and sperm production (Macleod et al. 2010), (Cowin et al. 2010), including exposure to phthalates (NTP 2005).</p>\n\n</p></div>", link_effecttoeffect15_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);
link_effecttoeffect15.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect15,dataSource,"Evidence Supporting Taxonomic Applicability","<p>Human and Rat see &quot;Empirical Support for Linkage&quot;</p>\n\n").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 2);
link_effecttoeffect15.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect15,dataSource,"Quantitative Understanding","<p>Evidence support: Unspecified</p><p></p>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 3);

link_effecttoeffect16 = new Link_EffectToEffect(pathway, dataSource,effect_downstreameffect9, effect_adverseoutcome3);
link_effecttoeffect16.setLinkType(LinkType.INDIRECT);link_effecttoeffect16.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect16,dataSource,"Description","<div class='description'><h3>Description</h3><p><p>Male sexual differentiation in general depends on testosterone (T), dihydrotestosterone (DHT), and the expression of androgen receptors by target cells (Manson and Carr 2003). Disturbances in the balance of this endocrine system by either endogenous or exogenous factors may lead to male reproductive tract, malformations (e.g. hypospadias, cryptorchidism). Reduction in T levels during foetal development subsequently lower levels of its metabolite DHT lead also to impaired growth of the perineum with reduced anogential distance (AGD) (Bowman et al. 2003).</p>\n\n</p></div><div class='references'><h3>References</h3><p><p>Andrade, Anderson J M, Simone W Grande, Chris E Talsness, Konstanze Grote, and Ibrahim Chahoud. 2006. &ldquo;A Dose-Response Study Following in Utero and Lactational Exposure to Di-(2-Ethylhexyl)-Phthalate (DEHP): Non-Monotonic Dose-Response and Low Dose Effects on Rat Brain Aromatase Activity.&rdquo; Toxicology 227 (3) (October 29): 185&ndash;92. doi:10.1016/j.tox.2006.07.022. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/16949715\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/16949715</a>.</p>\n\n<p>Barrett, Emily S, Lauren E Parlett, J Bruce Redmon, and Shanna H Swan. 2014. &ldquo;Evidence for Sexually Dimorphic Associations between Maternal Characteristics and Anogenital Distance, a Marker of Reproductive Development.&rdquo; American Journal of Epidemiology 179 (1) (January 1): 57&ndash;66. doi:10.1093/aje/kwt220. <a class=\"external free\" href=\"http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3864710&amp;tool=pmcentrez&amp;rendertype=abstract\" rel=\"nofollow\" target=\"_blank\">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3864710&amp;tool=pmcentrez&amp;rendertype=abstract</a>.</p>\n\n<p>Blaschko, Sarah D, Gerald R Cunha, and Laurence S Baskin. 2012. &ldquo;Molecular Mechanisms of External Genitalia Development.&rdquo; Differentiation; Research in Biological Diversity 84 (3) (October): 261&ndash;8. doi:10.1016/j.diff.2012.06.003. <a class=\"external free\" href=\"http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3443292&amp;tool=pmcentrez&amp;rendertype=abstract\" rel=\"nofollow\" target=\"_blank\">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3443292&amp;tool=pmcentrez&amp;rendertype=abstract</a>.</p>\n\n<p>Borch, Julie, Stine Broeng Metzdorff, Anne Marie Vinggaard, Leon Brokken, and Majken Dalgaard. 2006. &ldquo;Mechanisms Underlying the Anti-Androgenic Effects of Diethylhexyl Phthalate in Fetal Rat Testis.&rdquo; Toxicology 223 (1-2) (June 1): 144&ndash;55. doi:10.1016/j.tox.2006.03.015. <a class=\"external free\" href=\"http://www.sciencedirect.com/science/article/pii/S0300483X0600165X\" rel=\"nofollow\" target=\"_blank\">http://www.sciencedirect.com/science/article/pii/S0300483X0600165X</a>.</p>\n\n<p>Bornehag, Carl-Gustaf, Fredrik Carlstedt, Bo Ag J&ouml;nsson, Christian H Lindh, Tina K Jensen, Anna Bodin, Carin Jonsson, Staffan Janson, and Shanna H Swan. 2015. &ldquo;Prenatal Phthalate Exposures and Anogenital Distance in Swedish Boys.&rdquo; Environmental Health Perspectives 123 (1) (January): 101&ndash;7. doi:10.1289/ehp.1408163. <a class=\"external free\" href=\"http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4286276&amp;tool=pmcentrez&amp;rendertype=abstract\" rel=\"nofollow\" target=\"_blank\">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4286276&amp;tool=pmcentrez&amp;rendertype=abstract</a>.</p>\n\n<p>Bowman, Christopher J, Norman J Barlow, Katie J Turner, Duncan G Wallace, and Paul M D Foster. 2003. &ldquo;Effects of in Utero Exposure to Finasteride on Androgen-Dependent Reproductive Development in the Male Rat.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 74 (2) (August): 393&ndash;406. doi:10.1093/toxsci/kfg128. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/12773767\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/12773767</a>.</p>\n\n<p>Brouwers, Marijn M, Wouter F J Feitz, Luc A J Roelofs, Lambertus A L M Kiemeney, Robert P E de Gier, and Nel Roeleveld. 2007. &ldquo;Risk Factors for Hypospadias.&rdquo; European Journal of Pediatrics 166 (7) (July): 671&ndash;8. doi:10.1007/s00431-006-0304-z. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/17103190\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/17103190</a>.</p>\n\n<p>Brucker-Davis, Fran&ccedil;oise, Kathy Wagner-Mahler, Isabelle Delattre, B&eacute;atrice Ducot, Patricia Ferrari, Andr&eacute; Bongain, Jean-Yves Kurzenne, Jean-Christophe Mas, and Patrick F&eacute;nichel. 2008. &ldquo;Cryptorchidism at Birth in Nice Area (France) Is Associated with Higher Prenatal Exposure to PCBs and DDE, as Assessed by Colostrum Concentrations.&rdquo; Human Reproduction (Oxford, England) 23 (8) (August): 1708&ndash;18. doi:10.1093/humrep/den186. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/18503055\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/18503055</a>.</p>\n\n<p>Eisenberg, Michael L, Tina K Jensen, R Chanc Walters, Niels E Skakkebaek, and Larry I Lipshultz. 2011. &ldquo;The Relationship between Anogenital Distance and Reproductive Hormone Levels in Adult Men.&rdquo; The Journal of Urology 187 (2) (February): 594&ndash;8. doi:10.1016/j.juro.2011.10.041. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/22177168\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/22177168</a>.</p>\n\n<p>F&eacute;nichel, Patrick, Najiba Lahlou, Patrick Coquillard, Patricia Pana&iuml;a-Ferrari, Kathy Wagner-Mahler, and Fran&ccedil;oise Brucker-Davis. 2015. &ldquo;Cord Blood Insulin-like Peptide 3 (INSL3) but Not Testosterone Is Reduced in Idiopathic Cryptorchidism.&rdquo; Clinical Endocrinology 82 (2) (February): 242&ndash;7. doi:10.1111/cen.12500. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/24826892\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/24826892</a>.</p>\n\n<p>Gray, L E, J Ostby, J Furr, M Price, D N Veeramachaneni, and L Parks. 2000. &ldquo;Perinatal Exposure to the Phthalates DEHP, BBP, and DINP, but Not DEP, DMP, or DOTP, Alters Sexual Differentiation of the Male Rat.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 58 (2) (December): 350&ndash;65. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/11099647\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/11099647</a>.</p>\n\n<p>Hadziselimovic, F. 2002. &ldquo;Cryptorchidism, Its Impact on Male Fertility.&rdquo; European Urology 41 (2) (February): 121&ndash;3. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/12074397\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/12074397</a>. Hoshino, Nobuhito, Mayumi Iwai, and Yoshimasa Okazaki. 2005. &ldquo;A Two-Generation Reproductive Toxicity Study of Dicyclohexyl Phthalate in Rats.&rdquo; The Journal of Toxicological Sciences 30 Spec No (December): 79&ndash;96. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/16641545\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/16641545</a>.</p>\n\n<p>Huang, Po-Chin, Pao-Lin Kuo, Yen-Yin Chou, Shio-Jean Lin, and Ching-Chang Lee. 2009. &ldquo;Association between Prenatal Exposure to Phthalates and the Health of Newborns.&rdquo; Environment International 35 (1) (January): 14&ndash;20. doi:10.1016/j.envint.2008.05.012. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/18640725\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/18640725</a>. Jarfelt, Kirsten, Majken Dalgaard, Ulla Hass, Julie Borch, Helene Jacobsen, and Ole Ladefoged. 2005. &ldquo;Antiandrogenic Effects in Male Rats Perinatally Exposed to a Mixture of di(2-Ethylhexyl) Phthalate and di(2-Ethylhexyl) Adipate.&rdquo; Reproductive Toxicology (Elmsford, N.Y.) 19 (4): 505&ndash;15. doi:10.1016/j.reprotox.2004.11.005. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/15749265\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/15749265</a>.</p>\n\n<p>Johnson, Kamin J, Erin N McDowell, Megan P Viereck, and Jessie Q Xia. 2011. &ldquo;Species-Specific Dibutyl Phthalate Fetal Testis Endocrine Disruption Correlates with Inhibition of SREBP2-Dependent Gene Expression Pathways.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 120 (2) (April): 460&ndash;74. doi:10.1093/toxsci/kfr020. <a class=\"external free\" href=\"http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3061485&amp;tool=pmcentrez&amp;rendertype=abstract\" rel=\"nofollow\" target=\"_blank\">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3061485&amp;tool=pmcentrez&amp;rendertype=abstract</a>.</p>\n\n<p>Jurewicz, Joanna, and Wojciech Hanke. 2011. &ldquo;Exposure to Phthalates: Reproductive Outcome and Children Health. A Review of Epidemiological Studies.&rdquo; International Journal of Occupational Medicine and Environmental Health 24 (2) (June): 115&ndash;41. doi:10.2478/s13382-011-0022-2. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/21594692\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/21594692</a>. Kalfa, Nicolas, Pascal Philibert, and Charles Sultan. 2009. &ldquo;Is Hypospadias a Genetic, Endocrine or Environmental Disease, or Still an Unexplained Malformation?&rdquo; International Journal of Andrology 32 (3) (June): 187&ndash;97. doi:10.1111/j.1365-2605.2008.00899.x. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/18637150\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/18637150</a>.</p>\n\n<p>Klip, Helen, Janneke Verloop, Jan D van Gool, Marlies E T A Koster, Curt W Burger, and Flora E van Leeuwen. 2002. &ldquo;Hypospadias in Sons of Women Exposed to Diethylstilbestrol in Utero: A Cohort Study.&rdquo; Lancet 359 (9312) (March 30): 1102&ndash;7. doi:10.1016/S0140-6736(02)08152-7. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/11943257\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/11943257</a>.</p>\n\n<p>Macleod, D J, R M Sharpe, M Welsh, M Fisken, H M Scott, G R Hutchison, A J Drake, and S van den Driesche. 2010. &ldquo;Androgen Action in the Masculinization Programming Window and Development of Male Reproductive Organs.&rdquo; International Journal of Andrology 33 (2) (April): 279&ndash;87. doi:10.1111/j.1365-2605.2009.01005.x. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/20002220\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/20002220</a>. Manson, Jeanne M, and Michael C Carr. 2003. &ldquo;Molecular Epidemiology of Hypospadias: Review of Genetic and Environmental Risk Factors.&rdquo; Birth Defects Research. Part A, Clinical and Molecular Teratology 67 (10) (October): 825&ndash;36. doi:10.1002/bdra.10084. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/14745936\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/14745936</a>.</p>\n\n<p>McIntyre, B S, N J Barlow, and P M Foster. 2001. &ldquo;Androgen-Mediated Development in Male Rat Offspring Exposed to Flutamide in Utero: Permanence and Correlation of Early Postnatal Changes in Anogenital Distance and Nipple Retention with Malformations in Androgen-Dependent Tissues.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 62 (2) (August): 236&ndash;49. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/11452136\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/11452136</a>.</p>\n\n<p>McIntyre, B S, N J Barlow, D G Wallace, S C Maness, K W Gaido, and P M Foster. 2000. &ldquo;Effects of in Utero Exposure to Linuron on Androgen-Dependent Reproductive Development in the Male Crl:CD(SD)BR Rat.&rdquo; Toxicology and Applied Pharmacology 167 (2) (September 1): 87&ndash;99. doi:10.1006/taap.2000.8998. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/10964759\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/10964759</a>.</p>\n\n<p>Moore, R W, T A Rudy, T M Lin, K Ko, and R E Peterson. 2001. &ldquo;Abnormalities of Sexual Development in Male Rats with in Utero and Lactational Exposure to the Antiandrogenic Plasticizer Di(2-Ethylhexyl) Phthalate.&rdquo; Environmental Health Perspectives 109 (3) (March): 229&ndash;37. <a class=\"external free\" href=\"http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1240240&amp;tool=pmcentrez&amp;rendertype=abstract\" rel=\"nofollow\" target=\"_blank\">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1240240&amp;tool=pmcentrez&amp;rendertype=abstract</a>.</p>\n\n<p>Morales-Su&aacute;rez-Varela, Mar&iacute;a M, Gunnar V Toft, Morten S Jensen, Cecilia Ramlau-Hansen, Linda Kaerlev, Ane-Marie Thulstrup, Agust&iacute;n Llopis-Gonz&aacute;lez, J&oslash;rn Olsen, and Jens P Bonde. 2011. &ldquo;Parental Occupational Exposure to Endocrine Disrupting Chemicals and Male Genital Malformations: A Study in the Danish National Birth Cohort Study.&rdquo; Environmental Health : A Global Access Science Source 10 (1) (January): 3. doi:10.1186/1476-069X-10-3. <a class=\"external free\" href=\"http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3033238&amp;tool=pmcentrez&amp;rendertype=abstract\" rel=\"nofollow\" target=\"_blank\">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3033238&amp;tool=pmcentrez&amp;rendertype=abstract</a>.</p>\n\n<p>Murashima, Aki, Satoshi Kishigami, Axel Thomson, and Gen Yamada. 2015. &ldquo;Androgens and Mammalian Male Reproductive Tract Development.&rdquo; Biochimica et Biophysica Acta 1849 (2) (February): 163&ndash;170. doi:10.1016/j.bbagrm.2014.05.020. <a class=\"external free\" href=\"http://www.sciencedirect.com/science/article/pii/S1874939914001266\" rel=\"nofollow\" target=\"_blank\">http://www.sciencedirect.com/science/article/pii/S1874939914001266</a>.</p>\n\n<p>Mylchreest, Eve. 2000. &ldquo;Dose-Dependent Alterations in Androgen-Regulated Male Reproductive Development in Rats Exposed to Di(n-Butyl) Phthalate during Late Gestation.&rdquo; Toxicological Sciences 55 (1) (May 1): 143&ndash;151. doi:10.1093/toxsci/55.1.143. <a class=\"external free\" href=\"http://www.toxsci.oupjournals.org/cgi/doi/10.1093/toxsci/55.1.143\" rel=\"nofollow\" target=\"_blank\">http://www.toxsci.oupjournals.org/cgi/doi/10.1093/toxsci/55.1.143</a>.</p>\n\n<p>Mylchreest, Eve, Russell C. Cattley, and Paul M. D. Foster. 1998. &ldquo;Male Reproductive Tract Malformations in Rats Following Gestational and Lactational Exposure to Di( N -Butyl) Phthalate: An Antiandrogenic Mechanism?&rdquo; Toxicological Sciences 43 (1) (May 1): 47&ndash;60. doi:10.1093/toxsci/43.1.47. <a class=\"external free\" href=\"http://toxsci.oxfordjournals.org/content/43/1/47.short?rss=1&amp;ssource=mfc\" rel=\"nofollow\" target=\"_blank\">http://toxsci.oxfordjournals.org/content/43/1/47.short?rss=1&amp;ssource=mfc</a>.</p>\n\n<p>Parks, L. G. 2000. &ldquo;The Plasticizer Diethylhexyl Phthalate Induces Malformations by Decreasing Fetal Testosterone Synthesis during Sexual Differentiation in the Male Rat.&rdquo; Toxicological Sciences 58 (2) (December 1): 339&ndash;349. doi:10.1093/toxsci/58.2.339. <a class=\"external free\" href=\"http://toxsci.oxfordjournals.org/content/58/2/339.abstract\" rel=\"nofollow\" target=\"_blank\">http://toxsci.oxfordjournals.org/content/58/2/339.abstract</a>.</p>\n\n<p>Rey, Rodolfo A, Ethel Codner, Germ&aacute;n I&ntilde;&iacute;guez, Patricia Bedecarr&aacute;s, Romina Trigo, Cecilia Okuma, Silvia Gottlieb, Ignacio Bergad&aacute;, Stella M Campo, and Fernando G Cassorla. 2005. &ldquo;Low Risk of Impaired Testicular Sertoli and Leydig Cell Functions in Boys with Isolated Hypospadias.&rdquo; The Journal of Clinical Endocrinology and Metabolism 90 (11) (November): 6035&ndash;40. doi:10.1210/jc.2005-1306. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/16131574\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/16131574</a>.</p>\n\n<p>Saillenfait, Anne-Marie, Fr&eacute;d&eacute;ric Gallissot, and Jean-Philippe Sabat&eacute;. 2009. &ldquo;Differential Developmental Toxicities of Di-N-Hexyl Phthalate and Dicyclohexyl Phthalate Administered Orally to Rats.&rdquo; Journal of Applied Toxicology : JAT 29 (6) (August): 510&ndash;21. doi:10.1002/jat.1436. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/19391110\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/19391110</a>.</p>\n\n<p>Suzuki, Y, J Yoshinaga, Y Mizumoto, S Serizawa, and H Shiraishi. 2012. &ldquo;Foetal Exposure to Phthalate Esters and Anogenital Distance in Male Newborns.&rdquo; International Journal of Andrology 35 (3) (June): 236&ndash;44. doi:10.1111/j.1365-2605.2011.01190.x. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/21696396\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/21696396</a>.</p>\n\n<p>Swan, S. H., S. Sathyanarayana, E. S. Barrett, S. Janssen, F. Liu, R. H. N. Nguyen, and J. B. Redmon. 2015. &ldquo;First Trimester Phthalate Exposure and Anogenital Distance in Newborns.&rdquo; Human Reproduction 30 (4) (February 18): 963&ndash;72. doi:10.1093/humrep/deu363. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/25697839\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/25697839</a>.</p>\n\n<p>Swan, Shanna H, Katharina M Main, Fan Liu, Sara L Stewart, Robin L Kruse, Antonia M Calafat, Catherine S Mao, et al. 2005. &ldquo;Decrease in Anogenital Distance among Male Infants with Prenatal Phthalate Exposure.&rdquo; Environmental Health Perspectives 113 (8) (August): 1056&ndash;61. <a class=\"external free\" href=\"http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1280349&amp;tool=pmcentrez&amp;rendertype=abstract\" rel=\"nofollow\" target=\"_blank\">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1280349&amp;tool=pmcentrez&amp;rendertype=abstract</a>.</p>\n\n<p>Virtanen, Helena E, Dina Cortes, Ewa Rajpert-De Meyts, E Martin Ritz&eacute;n, Agneta Nordenskj&ouml;ld, Niels E Skakkebaek, and Jorma Toppari. 2007. &ldquo;Development and Descent of the Testis in Relation to Cryptorchidism.&rdquo; Acta Paediatrica (Oslo, Norway : 1992) 96 (5) (May): 622&ndash;7. doi:10.1111/j.1651-2227.2007.00244.x. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/17462055\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/17462055</a>.</p>\n\n<p>Wang, Ming-Hsien, and Laurence S Baskin. 2008. &ldquo;Endocrine Disruptors, Genital Development, and Hypospadias.&rdquo; Journal of Andrology 29 (5): 499&ndash;505. doi:10.2164/jandrol.108.004945. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/18497336\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/18497336</a>.</p>\n\n<p>Wilson, Vickie S, Christy Lambright, Johnathan Furr, Joseph Ostby, Carmen Wood, Gary Held, and L Earl Gray. 2004. &ldquo;Phthalate Ester-Induced Gubernacular Lesions Are Associated with Reduced insl3 Gene Expression in the Fetal Rat Testis.&rdquo; Toxicology Letters 146 (3) (March 2): 207&ndash;15. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/14687758\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/14687758</a>.</p>\n\n<p>Wolf, C., C. Lambright, P. Mann, M. Price, R. L. Cooper, J. Ostby, and L. E. Gray. 1999. &ldquo;Administration of Potentially Antiandrogenic Pesticides (procymidone, Linuron, Iprodione, Chlozolinate, P,p&rsquo;-DDE, and Ketoconazole) and Toxic Substances (dibutyl- and Diethylhexyl Phthalate, PCB 169, and Ethane Dimethane Sulphonate) during Sexual Differen.&rdquo; Toxicology and Industrial Health 15 (1-2) (February 1): 94&ndash;118. doi:10.1177/074823379901500109. <a class=\"external free\" href=\"http://tih.sagepub.com/content/15/1-2/94.abstract?ijkey=9190cbc3a5effe489f5f27911b833ff5e3f1a689&amp;keytype2=tf_ipsecsha\" rel=\"nofollow\" target=\"_blank\">http://tih.sagepub.com/content/15/1-2/94.abstract?ijkey=9190cbc3a5effe489f5f27911b833ff5e3f1a689&amp;keytype2=tf_ipsecsha</a>.</p>\n\n</p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
ReferenceIDW<Link_EffectToEffect> link_effecttoeffect16_weigth1= new ReferenceIDW<Link_EffectToEffect>(link_effecttoeffect16, dataSource, Link_EffectToEffect.class,3.0);
link_effecttoeffect16.getDescriptionIDs().set(new DescriptionSection_Structured(link_effecttoeffect16,dataSource,"(Key) Event Relationship Weight of Evidence","<div class='biological-plausibility'><h3>Biological Plausibility</h3><p><p><strong>Hypospadias</strong></p>\n\n<p>The role of foetal androgens (T and DHT) is crucial for the development of the male reproductive tract especially during the first trimester of pregnancy. Androgens regulate masculinization of external genitalia. T is necessary for stabilization and differentiation of the Wolffian structures (e.g., the epididymis, vas deferens and seminal vesicles) and also for normal development of the foetal testes; DHT, produced locally from testosterone, is required for normal development of the genital tubercle and urogenital sinus into the external genitalia and prostate (Murashima et al. 2015). Therefore any defects in androgen biosynthesis, metabolism or action during development can cause hypospadias (Rey et al. 2005). The environmental factors with anti-androgenic activity may alter the complex regulation of male sex differentiation during foetal life (Kalfa et al., 2008). Although the cause in most cases is unknown, hypospadias has been associated with aberrant androgen signalling during development (Wolf et al. 1999). The aetiology of this frequent malformation has not been elucidated despite intensive investigation (Kalfa, Philibert, and Sultan 2009). Hypospadias thus appears at the crossroads of genetic, endocrine and environmental mechanisms (Kalfa, Philibert, and Sultan 2009).</p>\n\n<p><strong>Anogential distance (AGD)</strong></p>\n\n<p>The anogenital distance (AGD) is a sexual dimorphism that results from the sex difference in foetal androgen (DHT) levels (Rhees et al., 1997). The AGD is a marker of perineal growth and caudal migration of the genital tubercle. It is androgen-dependent in male rodents (Bowman et al. 2003). During development, androgens stimulate the growth of the perineal region between the sex papilla and the anus, resulting in an increased AGD in male offspring (Bowman et al. 2003). The AGD, is believed to be a biomarker of prenatal androgen exposure in many species, and in humans it has been associated with several adverse reproductive health outcomes in adults. AGD reflects foetal androgen exposure only within a discrete masculinization programming window (MPW), during which development of male reproductive organs is taking place (Wolf et al. 1999), (Macleod et al. 2010).</p>\n\n<p><strong>Cryptorchidism</strong></p>\n\n<p>Undescended testis (UDT), also called cryptorchidism, is the most frequent congenital malformation in males, occurring in 2&ndash;5% of full-term male births (Hadziselimovic 2002) (Brucker-Davis et al. 2008). Testosterone and insulin-like peptide 3 (INSL3) are two major Leydig cell hormones that regulate physiological testicular descent during foetal development (Virtanen et al. 2007). Most cases of cryptorchidism remain idiopathic but epidemiological and experimental studies have suggested a role of both genetic and environmental factors. Studies e. g.(Gray et al. 2000) have shown that maternal administration of certain chemicals (phthalate esters) during the critical intrauterine period of sexual differentiation alters development of both androgen- and insl3-dependent tissues. Cryptorchidism is shown to be linked with increased risk of hypofertility and testicular cancer (F&eacute;nichel et al. 2015).</p>\n\n</p></div><div class='empirical-support-for-linkage'><h3>Empirical Support for Linkage</h3><p><p>Hypospadias</p>\n\n<p>Reduced T production during the male rat development lead to hypospadias (Mylchreest, Cattley, and Foster 1998), (Mylchreest 2000), (Gray et al. 2000), (Parks 2000), (Wilson et al. 2004); this outcome is associated with Leydig cell function.</p>\n\n<p>Anogential distance (AGD)</p>\n\n<p>The decreased AGD has been associated with the perturbation of androgen-mediated development of the reproductive tract in rat males which were exposed to anti-androgens in utero (Wolf et al. 1999), (McIntyre et al. 2000), (McIntyre, Barlow, and Foster 2001). Several studies have demonstrated that exposure to phthalates results in decreased anogenital distance in human males (S. H. Swan et al. 2015), (Bornehag et al. 2015), presumably due to lowered testosterone levels (Suzuki et al. 2012), (Jurewicz and Hanke 2011), (Shanna H Swan et al. 2005), for details see Table 1.</p>\n\n<table class=\"wikitable\" id=\"Event608\">\n\n	<tbody>\n\n		<tr>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p><strong>KE: testosterone, reduction</strong></p>\n\n			</td>\n\n			<td>\n\n			<p><strong>KE: AGD, decreased</strong></p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Compound</p>\n\n			</td>\n\n			<td>\n\n			<p>Species and strain: Doses: duration, [measurement day]</p>\n\n			</td>\n\n			<td>\n\n			<p>Effect level</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>Details</p>\n\n			</td>\n\n			<td>\n\n			<p>References</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat, 0, 10, 30, 100, or 300&nbsp;mg /kg bw/day : 7- 21 GD, [GD 21]</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=-300&nbsp;mg /kg bw/day</p>\n\n			</td>\n\n			<td>\n\n			<p>Testicular testosterone levels, reduction, no change plasma testosterone</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>(Borch et al. 2006)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat, GD 3- PND 21</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=750 mg /kg bw/day</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>Anogenital distance decreased</p>\n\n			</td>\n\n			<td>\n\n			<p>Gestational and lactational</p>\n\n			</td>\n\n			<td>\n\n			<p>(Moore et al. 2001)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=750 mg /kg bw/day</p>\n\n			</td>\n\n			<td>\n\n			<p>reduction in T production, and reduced testicular and whole-body T levels in fetal and neonatal male</p>\n\n			</td>\n\n			<td>\n\n			<p>Anogenital distance decreased</p>\n\n			</td>\n\n			<td>\n\n			<p>Exposure from (GD) 14 to postnatal day (PND) 3, AGD reduced by 36% in exposed male</p>\n\n			</td>\n\n			<td>\n\n			<p>(Parks 2000)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=15 mg /kg bw/day</p>\n\n			</td>\n\n			<td>\n\n			<p>Decreased testosterone levels</p>\n\n			</td>\n\n			<td>\n\n			<p>Effects on Sperm production</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>(Andrade et al. 2006)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=5 mg /kg bw/day</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>chryptorchidism</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>(Andrade et al. 2006)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=1.215 mg /kg bw/day</p>\n\n			</td>\n\n			<td>\n\n			<p>Decreased testosterone levels</p>\n\n			</td>\n\n			<td>\n\n			<p>Effects on Sperm production</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>(Andrade et al. 2006)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n			<td>&nbsp;</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DnHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=250 mg /kg bw/day</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>Anogenital distance decreased</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>(Saillenfait, Gallissot, and Sabat&eacute; 2009)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=300 mg/kg/day</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>Anogenital distance decreased</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>(Jarfelt et al. 2005)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=500 mg/kg/day</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>Anogenital distance decreased</p>\n\n			</td>\n\n			<td>\n\n			<p>throughout pregnancy until postnatal day 20</p>\n\n			</td>\n\n			<td>\n\n			<p>(Mylchreest, Cattley, and Foster 1998)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>dicyclohexyl phthalate (DCHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=6000 ppm</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>Anogenital distance decreased</p>\n\n			</td>\n\n			<td>\n\n			<p>F1 and F2 6000 ppm, and decrease of AGD and appearance of areola mammae were observed in the F1 male 6000 ppm and F2 male receiving doses of 1200 ppm or 6000 ppm.</p>\n\n			</td>\n\n			<td>\n\n			<p>(Hoshino, Iwai, and Okazaki 2005)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalate (DBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>rat</p>\n\n			</td>\n\n			<td>\n\n			<p>LOEL=500 mg/kg/day</p>\n\n			</td>\n\n			<td>\n\n			<p>intratesticular testosterone levels, reduction (by nearly 90%)</p>\n\n			</td>\n\n			<td>\n\n			<p>Anogenital distance decreased</p>\n\n			</td>\n\n			<td>\n\n			<p>GD 12 -20, examinations on GD20</p>\n\n			</td>\n\n			<td>\n\n			<p>(Johnson et al. 2011)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(MEHP)</p>\n\n			</td>\n\n			<td>\n\n			<p>Human</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>Anogenital index decreased</p>\n\n			</td>\n\n			<td>\n\n			<p>Urine concentration of phthalates metabolites MEHP associated with reduced AGI, suggestive association of sum of DEHP metabolites with reduced AGI</p>\n\n			</td>\n\n			<td>\n\n			<p>(Suzuki et al. 2012),</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates (MEP), (MBP), (MBzP), (MiBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>human</p>\n\n			</td>\n\n			<td>\n\n			<p>&nbsp;</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>Urinary concentrations of phthalate metabolites inversely related to AGI</p>\n\n			</td>\n\n			<td>\n\n			<p>134 boys 2-36 months of age</p>\n\n			</td>\n\n			<td>\n\n			<p>(Shanna H Swan et al. 2005)</p>\n\n			</td>\n\n		</tr>\n\n		<tr>\n\n			<td>\n\n			<p>Phthalates</p>\n\n			<p>(MEHP, MBP)</p>\n\n			</td>\n\n			<td>\n\n			<p>human</p>\n\n			</td>\n\n			<td>\n\n			<p>MBP= 78.4 ng/mL* in urine; 85.2&nbsp;ng/mL* in amniotic fluid</p>\n\n			<p>MEHP =24.9 ng/mL * in urine; 22.8&nbsp;ng/mL* in amniotic fluid</p>\n\n			</td>\n\n			<td>&nbsp;</td>\n\n			<td>\n\n			<p>In girls, decreased AGD in relation to amniotic fluid levels of MBP and MEHP. No associations found in boys</p>\n\n			</td>\n\n			<td>\n\n			<p>Amniotic fluid and urine concentrations of phthalate metabolites</p>\n\n			</td>\n\n			<td>\n\n			<p>(Huang et al. 2009)</p>\n\n			</td>\n\n		</tr>\n\n	</tbody>\n\n</table>\n\n<p>Table 1 Summary of experimental evidence for the KER. Lowest-Observed-Effect-Level (LOEL), Dibutyl phthalate (DBP), diisobutyl phthalate (DiBP), di-n-hexyl phthalate (DnHP), monobutyl phthalate (MBP); Bis(2-ethylhexyl) phthalate (DEHP) mono-(2-ethylhexyl) phthalate (MEHP); monoethyl phthalate (MEP), monobenzyl phthalate (MBzP), monoisobutyl phthalate (MiBP); anogenital index (AGI)-weight normalised index of AGD median.</p>\n\n</p></div><div class='uncertainties-or-inconsistencies'><h3>Uncertainties or Inconsistencies</h3><p><p>Hypospadias</p>\n\n<p>Epidemiological studies have demonstrated an association between foetal estrogen exposure and hypospadias (Klip et al. 2002), (Brouwers et al. 2007). However, the molecular mechanism underlying this association is unknown (Wang and Baskin 2008), (Blaschko, Cunha, and Baskin 2012).</p>\n\n<p><br />\n\nAnogential distance (AGD)</p>\n\n<p>Study by Huang et al did not found associations with the phthalates metabolites in the male AGD, however in females in relation to amniotic fluid levels of MBP and MEHP (Huang et al. 2009).</p>\n\n</p></div>", link_effecttoeffect16_weigth1).setFormat(ContentFormat.HTML).<DescriptionSection_Structured> makeItLive(), 1);
link_effecttoeffect16.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect16,dataSource,"Evidence Supporting Taxonomic Applicability","<p>Hypospadias</p>\n\n<p>Maternal exposure to estrogenic and antiandrogenic endocrine disrupting compounds has been implicated in increased risk of cryptorchidism and hypospadias in human male offspring without statistical significance (Morales-Su&aacute;rez-Varela et al. 2011).</p>\n\n<p>AGD</p>\n\n<p>Across numerous species, including humans, AGD is longer in males compared to females; for review see (Barrett et al. 2014).</p>\n\n").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 2);
link_effecttoeffect16.getDescriptionIDs().set(new DescriptionSection(link_effecttoeffect16,dataSource,"Quantitative Understanding","<p>Evidence support: Unspecified</p><p></p>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 3);

pathway.getGroups().parseString("");
pathway.getUids().parseString("SHORTNAME:PPARα activation leading to impaired fertility,");
pathway.getStatus().parseString("OECD:EAGMST Under Review,SAAOP:Included in OECD Work Plan,AOPWIKI:Open for citation & comment,");

pathway.updateEssentiality();
EssetialityDescription essentiality = pathway.getEssentiality();
DescriptionSection_Structured dss;
pathway.getDescriptionIDs().set(new DescriptionSection(pathway,dataSource,"Abstract","<div class='abstract'><h3>Abstract</h3><p><p>This AOP links the activation of Peroxisome Proliferator Activated Receptor &alpha; (PPAR&alpha;) to the developmental/reproductive toxicity in male. The development of this AOP relies on evidence collected from rodent models and incorporates human mechanistic and epidemiological data. The PPAR&alpha; is a ligand-activated transcription factor that belongs to the nuclear receptor family, which also includes the steroid and thyroid hormone receptors. The hypothesis that PPAR&alpha; action is the mechanistic basis for effects on the reproductive system arises from limited experimental data indicating relationships between activation of this receptor and impairment of steroidogenesis leading to reproductive toxicity. PPARs play important roles in the metabolic regulation of lipids, of which cholesterol, in particular, being a precursor of steroid hormones, makes the link between lipid metabolism to effects on reproduction. The key events in the pathway comprise the activation of PPAR&alpha;, followed by the disruption cholesterol transport in mitochondria, impairment of hormonal balance which leads to malformation of the reproductive tract in males which may lead to impaired fertility. The PPAR&alpha;-initiated AOP to rodent male developmental toxicity is a first step for structuring current knowledge about a mode of action which is neither AR-mediated nor via direct steroidogenesis enzymes inhibition. In the current form the pathway lays a strong basis for linking an endocrine mode of action with an apical endpoint, a prerequisite requirement for the identification of endocrine disrupting chemicals. This AOP is complemented with a structured data collection which will serve as the basis for further quantitative development of the pathway.</p>\n\n</p></div><div class='references'><h3>References</h3><p><p>Akingbemi, B. T. 2001. &ldquo;Modulation of Rat Leydig Cell Steroidogenic Function by Di(2-Ethylhexyl)Phthalate.&rdquo; Biology of Reproduction 65 (4) (October 1): 1252&ndash;1259. doi:10.1095/biolreprod65.4.1252. <a class=\"external free\" href=\"http://www.biolreprod.org/content/65/4/1252.long\" rel=\"nofollow\" target=\"_blank\">http://www.biolreprod.org/content/65/4/1252.long</a>.</p>\n\n<p>Arlt, W, R J Auchus, and W L Miller. 2001. &ldquo;Thiazolidinediones but Not Metformin Directly Inhibit the Steroidogenic Enzymes P450c17 and 3beta -Hydroxysteroid Dehydrogenase.&rdquo; The Journal of Biological Chemistry 276 (20) (May 18): 16767&ndash;71. doi:10.1074/jbc.M100040200. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/11278997\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/11278997</a>.</p>\n\n<p>Barak, Y, M C Nelson, E S Ong, Y Z Jones, P Ruiz-Lozano, K R Chien, A Koder, and R M Evans. 1999. &ldquo;PPAR Gamma Is Required for Placental, Cardiac, and Adipose Tissue Development.&rdquo; Molecular Cell 4 (4) (October): 585&ndash;95. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/10549290\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/10549290</a>.</p>\n\n<p>Bloomgarden, Z T, W Futterweit, and L Poretsky. 2001. &ldquo;Use of Insulin-Sensitizing Agents in Patients with Polycystic Ovary Syndrome.&rdquo; Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 7 (4): 279&ndash;86. doi:10.4158/EP.7.4.279. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/11497481\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/11497481</a>.</p>\n\n<p>Boberg, Julie, Stine Metzdorff, Rasmus Wortziger, Marta Axelstad, Leon Brokken, Anne Marie Vinggaard, Majken Dalgaard, and Christine Nellemann. 2008. &ldquo;Impact of Diisobutyl Phthalate and Other PPAR Agonists on Steroidogenesis and Plasma Insulin and Leptin Levels in Fetal Rats.&rdquo; Toxicology 250 (2-3) (September 4): 75&ndash;81. doi:10.1016/j.tox.2008.05.020. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/18602967\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/18602967</a>.</p>\n\n<p>Borch, Julie, Stine Broeng Metzdorff, Anne Marie Vinggaard, Leon Brokken, and Majken Dalgaard. 2006. &ldquo;Mechanisms Underlying the Anti-Androgenic Effects of Diethylhexyl Phthalate in Fetal Rat Testis.&rdquo; Toxicology 223 (1-2) (June 1): 144&ndash;55. doi:10.1016/j.tox.2006.03.015. <a class=\"external free\" href=\"http://www.sciencedirect.com/science/article/pii/S0300483X0600165X\" rel=\"nofollow\" target=\"_blank\">http://www.sciencedirect.com/science/article/pii/S0300483X0600165X</a>.</p>\n\n<p>Corton, J Christopher, Michael L Cunningham, B Timothy Hummer, Christopher Lau, Bette Meek, Jeffrey M Peters, James A Popp, Lorenz Rhomberg, Jennifer Seed, and James E Klaunig. 2014. &ldquo;Mode of Action Framework Analysis for Receptor-Mediated Toxicity: The Peroxisome Proliferator-Activated Receptor Alpha (PPAR&alpha;) as a Case Study.&rdquo; Critical Reviews in Toxicology 44 (1) (January): 1&ndash;49. doi:10.3109/10408444.2013.835784. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/24180432\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/24180432</a>.</p>\n\n<p>Corton, J. Christopher, and Paula J Lapinskas. 2004. &ldquo;Peroxisome Proliferator-Activated Receptors: Mediators of Phthalate Ester-Induced Effects in the Male Reproductive Tract?&rdquo; Toxicological Sciences 83 (1) (October 13): 4&ndash;17. doi:10.1093/toxsci/kfi011. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/15496498\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/15496498</a>.</p>\n\n<p>Couto, Jana&iacute;na A, Karina L A Saraiva, Cleiton D Barros, Daniel P Udrisar, Christina A Peixoto, Juliany S B C&eacute;sar Vieira, Maria C Lima, Suely L Galdino, Ivan R Pitta, and Maria I Wanderley. 2010. &ldquo;Effect of Chronic Treatment with Rosiglitazone on Leydig Cell Steroidogenesis in Rats: In Vivo and Ex Vivo Studies.&rdquo; Reproductive Biology and Endocrinology : RB&amp;E 8 (1) (January): 13. doi:10.1186/1477-7827-8-13. <a class=\"external free\" href=\"http://www.rbej.com/content/8/1/13\" rel=\"nofollow\" target=\"_blank\">http://www.rbej.com/content/8/1/13</a>.</p>\n\n<p>David, RM. 2006. &ldquo;Proposed Mode of Action for in Utero Effects of Some Phthalate Esters on the Developing Male Reproductive Tract.&rdquo; Toxicologic Pathology. doi:10.1080/01926230600642625. <a class=\"external free\" href=\"http://tpx.sagepub.com/content/34/3/209.short\" rel=\"nofollow\" target=\"_blank\">http://tpx.sagepub.com/content/34/3/209.short</a>.</p>\n\n<p>Dunaif, A, D Scott, D Finegood, B Quintana, and R Whitcomb. 1996. &ldquo;The Insulin-Sensitizing Agent Troglitazone Improves Metabolic and Reproductive Abnormalities in the Polycystic Ovary Syndrome.&rdquo; The Journal of Clinical Endocrinology and Metabolism 81 (9) (September): 3299&ndash;306. doi:10.1210/jcem.81.9.8784087. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/8784087\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/8784087</a>.</p>\n\n<p>Ema, Makoto. 2002. &ldquo;Antiandrogenic Effects of Dibutyl Phthalate and Its Metabolite, Monobutyl Phthalate, in Rats.&rdquo; Congenital Anomalies 42 (4) (December): 297&ndash;308. doi:10.1111/j.1741-4520.2002.tb00896.x. <a class=\"external free\" href=\"http://doi.wiley.com/10.1111/j.1741-4520.2002.tb00896.x\" rel=\"nofollow\" target=\"_blank\">http://doi.wiley.com/10.1111/j.1741-4520.2002.tb00896.x</a>.</p>\n\n<p>Furr, Johnathan R, Christy S Lambright, Vickie S Wilson, Paul M Foster, and Leon E Gray. 2014. &ldquo;A Short-Term in Vivo Screen Using Fetal Testosterone Production, a Key Event in the Phthalate Adverse Outcome Pathway, to Predict Disruption of Sexual Differentiation.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 140 (2) (August 1): 403&ndash;24. doi:10.1093/toxsci/kfu081. <a class=\"external free\" href=\"http://toxsci.oxfordjournals.org/content/140/2/403.full\" rel=\"nofollow\" target=\"_blank\">http://toxsci.oxfordjournals.org/content/140/2/403.full</a>.</p>\n\n<p>Gasic, S, Y Bodenburg, M Nagamani, A Green, and R J Urban. 1998. &ldquo;Troglitazone Inhibits Progesterone Production in Porcine Granulosa Cells.&rdquo; Endocrinology 139 (12) (December): 4962&ndash;6. doi:10.1210/endo.139.12.6385. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/9832434\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/9832434</a>.</p>\n\n<p>Gasic, S, M Nagamani, A Green, and R J Urban. 2001. &ldquo;Troglitazone Is a Competitive Inhibitor of 3beta-Hydroxysteroid Dehydrogenase Enzyme in the Ovary.&rdquo; American Journal of Obstetrics and Gynecology 184 (4) (March): 575&ndash;9. doi:10.1067/mob.2001.111242. <a class=\"external free\" href=\"http://www.sciencedirect.com/science/article/pii/S0002937801774340\" rel=\"nofollow\" target=\"_blank\">http://www.sciencedirect.com/science/article/pii/S0002937801774340</a>.</p>\n\n<p>Gazouli, M. 2002. &ldquo;Effect of Peroxisome Proliferators on Leydig Cell Peripheral-Type Benzodiazepine Receptor Gene Expression, Hormone-Stimulated Cholesterol Transport, and Steroidogenesis: Role of the Peroxisome Proliferator-Activator Receptor .&rdquo; Endocrinology 143 (7) (July 1): 2571&ndash;2583. doi:10.1210/en.143.7.2571. <a class=\"external free\" href=\"http://endo.endojournals.org/content/143/7/2571\" rel=\"nofollow\" target=\"_blank\">http://endo.endojournals.org/content/143/7/2571</a>.</p>\n\n<p>Hannas, Bethany R, Christy S Lambright, Johnathan Furr, Nicola Evans, Paul M D Foster, Earl L Gray, and Vickie S Wilson. 2012. &ldquo;Genomic Biomarkers of Phthalate-Induced Male Reproductive Developmental Toxicity: A Targeted RT-PCR Array Approach for Defining Relative Potency.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 125 (2) (February): 544&ndash;57. doi:10.1093/toxsci/kfr315. <a class=\"external free\" href=\"http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3262859&amp;tool=pmcentrez&amp;rendertype=abstract\" rel=\"nofollow\" target=\"_blank\">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3262859&amp;tool=pmcentrez&amp;rendertype=abstract</a>.</p>\n\n<p>Heindel, J J, D K Gulati, R C Mounce, S R Russell, and J C Lamb. 1989. &ldquo;Reproductive Toxicity of Three Phthalic Acid Esters in a Continuous Breeding Protocol.&rdquo; Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology 12 (3) (April): 508&ndash;18. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/2731665\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/2731665</a>.</p>\n\n<p>Johnson, Kamin J, Nicholas E Heger, and Kim Boekelheide. 2012. &ldquo;Of Mice and Men (and Rats): Phthalate-Induced Fetal Testis Endocrine Disruption Is Species-Dependent.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 129 (2) (October): 235&ndash;48. doi:10.1093/toxsci/kfs206. <a class=\"external free\" href=\"http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3491958&amp;tool=pmcentrez&amp;rendertype=abstract\" rel=\"nofollow\" target=\"_blank\">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3491958&amp;tool=pmcentrez&amp;rendertype=abstract</a>.</p>\n\n<p>Kempn&aacute;, Petra, Gaby Hofer, Primus E Mullis, and Christa E Fl&uuml;ck. 2007. &ldquo;Pioglitazone Inhibits Androgen Production in NCI-H295R Cells by Regulating Gene Expression of CYP17 and HSD3B2.&rdquo; Molecular Pharmacology 71 (3) (March): 787&ndash;98. doi:10.1124/mol.106.028902. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/17138841\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/17138841</a>.</p>\n\n<p>Kuhl, Adam J, Susan M Ross, and Kevin W Gaido. 2007. &ldquo;CCAAT/enhancer Binding Protein Beta, but Not Steroidogenic Factor-1, Modulates the Phthalate-Induced Dysregulation of Rat Fetal Testicular Steroidogenesis.&rdquo; Endocrinology 148 (12) (December): 5851&ndash;64. doi:10.1210/en.2007-0930. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/17884934\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/17884934</a>.</p>\n\n<p>Lapinskas, Paula J., Sherri Brown, Lisa M. Leesnitzer, Steven Blanchard, Cyndi Swanson, Russell C. Cattley, and J. Christopher Corton. 2005. &ldquo;Role of PPAR&alpha; in Mediating the Effects of Phthalates and Metabolites in the Liver.&rdquo; Toxicology 207 (1): 149&ndash;163. <a class=\"external free\" href=\"http://www.sciencedirect.com/science/article/pii/S0300483X04005633\" rel=\"nofollow\" target=\"_blank\">http://www.sciencedirect.com/science/article/pii/S0300483X04005633</a>.</p>\n\n<p>Latini, Giuseppe, Egeria Scoditti, Alberto Verrotti, Claudio De Felice, and Marika Massaro. 2008. &ldquo;Peroxisome Proliferator-Activated Receptors as Mediators of Phthalate-Induced Effects in the Male and Female Reproductive Tract: Epidemiological and Experimental Evidence.&rdquo; PPAR Research 2008 (January): 359267. doi:10.1155/2008/359267. <a class=\"external free\" href=\"http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2225463&amp;tool=pmcentrez&amp;rendertype=abstract\" rel=\"nofollow\" target=\"_blank\">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2225463&amp;tool=pmcentrez&amp;rendertype=abstract</a>.</p>\n\n<p>Lehmann, Kim P, Suzanne Phillips, Madhabananda Sar, Paul M D Foster, and Kevin W Gaido. 2004. &ldquo;Dose-Dependent Alterations in Gene Expression and Testosterone Synthesis in the Fetal Testes of Male Rats Exposed to Di (n-Butyl) Phthalate.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 81 (1) (September 1): 60&ndash;8. doi:10.1093/toxsci/kfh169. <a class=\"external free\" href=\"http://toxsci.oxfordjournals.org/content/81/1/60.abstract?ijkey=99364980d6548f969a82406deb6600873a38be36&amp;keytype2=tf_ipsecsha\" rel=\"nofollow\" target=\"_blank\">http://toxsci.oxfordjournals.org/content/81/1/60.abstract?ijkey=99364980d6548f969a82406deb6600873a38be36&amp;keytype2=tf_ipsecsha</a>.</p>\n\n<p>Minge, Cadence E, Rebecca L Robker, and Robert J Norman. 2008. &ldquo;PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility.&rdquo; PPAR Research 2008 (January): 243791. doi:10.1155/2008/243791. <a class=\"external free\" href=\"http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2246065&amp;tool=pmcentrez&amp;rendertype=abstract\" rel=\"nofollow\" target=\"_blank\">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2246065&amp;tool=pmcentrez&amp;rendertype=abstract</a>.</p>\n\n<p>Mu, Y M, T Yanase, Y Nishi, N Waseda, T Oda, A Tanaka, R Takayanagi, and H Nawata. 2000. &ldquo;Insulin Sensitizer, Troglitazone, Directly Inhibits Aromatase Activity in Human Ovarian Granulosa Cells.&rdquo; Biochemical and Biophysical Research Communications 271 (3) (May 19): 710&ndash;3. doi:10.1006/bbrc.2000.2701. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/10814527\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/10814527</a>.</p>\n\n<p>Mylchreest, Eve. 2000. &ldquo;Dose-Dependent Alterations in Androgen-Regulated Male Reproductive Development in Rats Exposed to Di(n-Butyl) Phthalate during Late Gestation.&rdquo; Toxicological Sciences 55 (1) (May 1): 143&ndash;151. doi:10.1093/toxsci/55.1.143. <a class=\"external free\" href=\"http://www.toxsci.oupjournals.org/cgi/doi/10.1093/toxsci/55.1.143\" rel=\"nofollow\" target=\"_blank\">http://www.toxsci.oupjournals.org/cgi/doi/10.1093/toxsci/55.1.143</a>.</p>\n\n<p>Mylchreest, Eve, Russell C. Cattley, and Paul M. D. Foster. 1998. &ldquo;Male Reproductive Tract Malformations in Rats Following Gestational and Lactational Exposure to Di( N -Butyl) Phthalate: An Antiandrogenic Mechanism?&rdquo; Toxicological Sciences 43 (1) (May 1): 47&ndash;60. doi:10.1093/toxsci/43.1.47. <a class=\"external free\" href=\"http://toxsci.oxfordjournals.org/content/43/1/47.short?rss=1&amp;ssource=mfc\" rel=\"nofollow\" target=\"_blank\">http://toxsci.oxfordjournals.org/content/43/1/47.short?rss=1&amp;ssource=mfc</a>.</p>\n\n<p>Peters, J M, M W Taubeneck, C L Keen, and F J Gonzalez. 1997. &ldquo;Di(2-Ethylhexyl) Phthalate Induces a Functional Zinc Deficiency during Pregnancy and Teratogenesis That Is Independent of Peroxisome Proliferator-Activated Receptor-Alpha.&rdquo; Teratology 56 (5) (November): 311&ndash;6. doi:10.1002/(SICI)1096-9926(199711)56:5&lt;311::AID-TERA4&gt;3.0.CO;2-#. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/9451755\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/9451755</a>.</p>\n\n<p>Shipley, Jonathan M, and David J Waxman. 2004. &ldquo;Simultaneous, Bidirectional Inhibitory Crosstalk between PPAR and STAT5b.&rdquo; Toxicology and Applied Pharmacology 199 (3) (October 15): 275&ndash;84. doi:10.1016/j.taap.2003.12.020. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/15364543\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/15364543</a>.</p>\n\n<p>Shultz, V. D. 2001. &ldquo;Altered Gene Profiles in Fetal Rat Testes after in Utero Exposure to Di(n-Butyl) Phthalate.&rdquo; Toxicological Sciences 64 (2) (December 1): 233&ndash;242. doi:10.1093/toxsci/64.2.233. <a class=\"external free\" href=\"http://toxsci.oxfordjournals.org/content/64/2/233.abstract?ijkey=b8af27acfe10695847a4e8a9b568882405d071ae&amp;keytype2=tf_ipsecsha\" rel=\"nofollow\" target=\"_blank\">http://toxsci.oxfordjournals.org/content/64/2/233.abstract?ijkey=b8af27acfe10695847a4e8a9b568882405d071ae&amp;keytype2=tf_ipsecsha</a>.</p>\n\n<p>Thompson, Christopher J, Susan M Ross, Janan Hensley, Kejun Liu, Susanna C Heinze, S Stanley Young, and Kevin W Gaido. 2005. &ldquo;Differential Steroidogenic Gene Expression in the Fetal Adrenal Gland versus the Testis and Rapid and Dynamic Response of the Fetal Testis to Di(n-Butyl) Phthalate.&rdquo; Biology of Reproduction 73 (5) (November): 908&ndash;17. doi:10.1095/biolreprod.105.042382. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/15987825\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/15987825</a>.</p>\n\n<p>Veldhuis, Johannes D, George Zhang, and James C Garmey. 2002. &ldquo;Troglitazone, an Insulin-Sensitizing Thiazolidinedione, Represses Combined Stimulation by LH and Insulin of de Novo Androgen Biosynthesis by Thecal Cells in Vitro.&rdquo; The Journal of Clinical Endocrinology and Metabolism 87 (3) (March): 1129&ndash;33. doi:10.1210/jcem.87.3.8308. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/11889176\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/11889176</a>.</p>\n\n<p>Vierhapper, H, P Nowotny, and W Waldh&auml;usl. 2003. &ldquo;Reduced Production Rates of Testosterone and Dihydrotestosterone in Healthy Men Treated with Rosiglitazone.&rdquo; Metabolism: Clinical and Experimental 52 (2) (February): 230&ndash;2. doi:10.1053/meta.2003.50028. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/12601638\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/12601638</a>.</p>\n\n<p>Ward, J M, J M Peters, C M Perella, and F J Gonzalez. 1998. &ldquo;Receptor and Nonreceptor-Mediated Organ-Specific Toxicity of di(2-Ethylhexyl)phthalate (DEHP) in Peroxisome Proliferator-Activated Receptor Alpha-Null Mice.&rdquo; Toxicologic Pathology 26 (2): 240&ndash;6. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/9547862\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/9547862</a>.</p>\n\n<p>Welsh, Michelle, Philippa T K Saunders, Mark Fisken, Hayley M Scott, Gary R Hutchison, Lee B Smith, and Richard M Sharpe. 2008. &ldquo;Identification in Rats of a Programming Window for Reproductive Tract Masculinization, Disruption of Which Leads to Hypospadias and Cryptorchidism.&rdquo; The Journal of Clinical Investigation 118 (4) (April): 1479&ndash;90. doi:10.1172/JCI34241. <a class=\"external free\" href=\"http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2267017&amp;tool=pmcentrez&amp;rendertype=abstract\" rel=\"nofollow\" target=\"_blank\">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2267017&amp;tool=pmcentrez&amp;rendertype=abstract</a>.</p>\n\n<p>Wood, Charles E, Micheal P Jokinen, Crystal L Johnson, Greg R Olson, Susan Hester, Michael George, Brian N Chorley, et al. 2014. &ldquo;Comparative Time Course Profiles of Phthalate Stereoisomers in Mice.&rdquo; Toxicological Sciences : An Official Journal of the Society of Toxicology 139 (1) (May): 21&ndash;34. doi:10.1093/toxsci/kfu025. <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/pubmed/24496636\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/pubmed/24496636</a>.</p>\n\n</p></div>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 0);
pathway.getDescriptionIDs().set(new DescriptionSection(pathway,dataSource,"Background","").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 1);
pathway.getDescriptionIDs().set(new DescriptionSection(pathway,dataSource,"Essentiality Support","").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 2);
pathway.getDescriptionIDs().set(new DescriptionSection(pathway,dataSource,"Quantitative Considerations","<p>This AOP is qualitatively described; however it contains also data that may be used for further development of quantitative description.</p>\n\n").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 3);
pathway.getDescriptionIDs().set(new DescriptionSection(pathway,dataSource,"Applicability of the AOP","<div class='summary'><h3>Summary</h3><p><p>Empirical information on dose-response relationships between the KEs, are not available, however there are solid empirical data that would inform a computational, predictive model for reproductive toxicity via PPAR&alpha; activation.</p>\n\n<p><strong>Life Stage Applicability</strong></p>\n\n<p>This AOP is relevant for developing (prenatal) male.</p>\n\n<p><strong>Taxonomic Applicability</strong></p>\n\n<p>The experimental support for the pathway is mainly based on the animal (rat studies). Conflicting reports comes from the studies on mouse. Studies in mice report contradictory results. Recently, studies by Furr et al revealed that fetal T production can be inhibited by exposure to a phthalates in utero (CD-1 mice), but at a higher dose level than required in rats and causing systemic effects (Furr et al. 2014). However there are some earlier reports that chronic dietary administration of phthalates produces adverse testicular effects and reduces fertility in CD-1 mice (Heindel et al. 1989)</p>\n\n<p><strong>Sex Applicability</strong></p>\n\n<p>This AOP applies to males only.</p>\n\n</p></div><ul><li><strong>Sexes</strong>:Male</li><li><strong>Life Stages</strong>:Development</li><li><strong>Taxonomies</strong>:Rattus norvegicus, Homo sapiens, Mus musculus</li></ul>").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 4);
pathway.getDescriptionIDs().set(new DescriptionSection(pathway,dataSource,"Potential Applications of the AOP","<p>1. The AOP describes a pathway which allows for the detection of sex steroid--related endocrine disrupting modes of action, with focus on the identification of substances which affect the reproductive system. In the current form the pathway lays a strong basis for linking endocrine mode of action with an apical endpoint, a prerequisite requirement for identification of endocrine disrupting chemicals (EDC).</p>\n\n<p>EDCs require specific evaluation under REACH (1907/2006, Registration, Evaluation, Authorisation and Restriction of Chemicals (EU, 2006)), the revised European plant protection product regulation 1107/2009 (EU, 2009) and use of biocidal products 528/2012 EC (EU, 2012).Amongst other agencies the US EPA is also giving particular attention to EDCs (EPA, 1998).</p>\n\n<p>2. This AOP structurally represents current knowledge of the pathway from PPAR&alpha; activation to impaired fertility that may provide a basis for development (and interpretation) of strategies for Integrated Approaches to Testing Assessment (IATA) to identify similar substances that may operate via the same pathway related tosex steroids disruptionand effects on reproductive tract and fertility. This AOP forms the starting point on an AOP network mapping to modes of action for endocrine disruption.</p>\n\n<p>3. The AOP could inform the development of quantitative structure activity relationships, read-across models, and/or systems biology models to prioritize chemicals for further testing.</p>\n\n").setFormat(ContentFormat.HTML).<DescriptionSection> makeItLive(), 5);
dss = essentiality.getEssentialityDescription(effect_molecularinitiatingevent1);
dss.setContent("Section content");
dss.setFormat(ContentFormat.TEXT);
((ReferenceIDW<Link_EffectToEffect>) dss.getStructuredContent()).setWeight(1.0);
dss = essentiality.getEssentialityDescription(effect_adverseoutcome2);
dss.setContent("Section content");
dss.setFormat(ContentFormat.TEXT);
((ReferenceIDW<Link_EffectToEffect>) dss.getStructuredContent()).setWeight(0.0);
dss = essentiality.getEssentialityDescription(effect_adverseoutcome3);
dss.setContent("Section content");
dss.setFormat(ContentFormat.TEXT);
((ReferenceIDW<Link_EffectToEffect>) dss.getStructuredContent()).setWeight(0.0);
dss = essentiality.getEssentialityDescription(effect_downstreameffect4);
dss.setContent("Section content");
dss.setFormat(ContentFormat.TEXT);
((ReferenceIDW<Link_EffectToEffect>) dss.getStructuredContent()).setWeight(1.0);
dss = essentiality.getEssentialityDescription(effect_downstreameffect5);
dss.setContent("Section content");
dss.setFormat(ContentFormat.TEXT);
((ReferenceIDW<Link_EffectToEffect>) dss.getStructuredContent()).setWeight(2.0);
dss = essentiality.getEssentialityDescription(effect_downstreameffect7);
dss.setContent("Section content");
dss.setFormat(ContentFormat.TEXT);
((ReferenceIDW<Link_EffectToEffect>) dss.getStructuredContent()).setWeight(2.0);
dss = essentiality.getEssentialityDescription(effect_downstreameffect9);
dss.setContent("Section content");
dss.setFormat(ContentFormat.TEXT);
((ReferenceIDW<Link_EffectToEffect>) dss.getStructuredContent()).setWeight(2.0);
dss = essentiality.getEssentialityDescription(effect_downstreameffect12);
dss.setContent("Section content");
dss.setFormat(ContentFormat.TEXT);
((ReferenceIDW<Link_EffectToEffect>) dss.getStructuredContent()).setWeight(1.0);
dss = essentiality.getEssentialityDescription(effect_downstreameffect14);
dss.setContent("Section content");
dss.setFormat(ContentFormat.TEXT);
((ReferenceIDW<Link_EffectToEffect>) dss.getStructuredContent()).setWeight(0.0);
}
}
